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ABSTRACT
Since 1986 in Western Australia many pharmacists have been supplying needles
and syringes to injecting drug users as part of the governments's hann
minimisation policy to prevent the spread of HIVIAIDS and other blood-borne
viruses, particularly the more recently recognised hepotitis C. This practice was
technically illegal, although officially condoned, until May 1994. Adequate
baseline data not was available concerning needle and syringe supply or the

attitudes of pha.rmacists concerning this issue. In this study a mail survey of
Western Australian community pharmacists was conducted to determine the
proportion of pharmacists currently supplying needles and syringes to injecting
drug users, the factors that have influenced supply practice over time and the

factors differentiating betwr.:en current sellers and nonsellers. A stratified random
sample of 130 pharmacists was selected from the population of 466 metropolitrm
and country pharmacists. Prior.to lho mail-out pharmacists were telephoned to
inform them of the study, ask them to participate and ascertain their supply

practice, after which questionnaires were posted to consenting pharmacists. Two
follow-up calls were madeto non-respondents. From 129 forwarded 115 useable
questionnaires were returned comprising 74 from the city and 41 from the
country, a response rate of 88%. The results found that 88% of pharmacists were
currently supplying needles and syringes to injecting drug users, 86% of
metropolitrm and 90% of country pharmacists. Eight percent of pharmacists were
past sellers and 4% had never sold. The commonest factors rated by current
11

· sellers as important in thei,. decision to supply needles and syringes was the belief
that it was essential to the reduction of the transmission of disease ( 92%) and
belief that disruption was unlikely to occur (78%). Disruption in their pharmacy
(89'%) and threatening incidents (78%) were the main reasons past sellers ceased
supply. The major differentiating factor concerning supply practice was that
nonsellers were more likely than seUers to have experienced disruptive incidents

in their pharmacy, r (113)

~

-.37 I!< .01. The fmdings indicate that the vast

majority of pharmacists currently supply needles and syringes and were not
unduly influenced by the fonner legal sanctions. There are some implications for

support and/or training for pharmacists in relation to needle and syringe supply.
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CHAPTER ONE

Introduction

Since 1987 pharmacists in Western Australia have been encouraged to sell
needles and syringes to injecting drug users as part of the governments harm
minimisation strategy for the prevention of the spread of the human

immunodeficiency virus (HIV). the organism that causes the auto immune
deficiency syndrome (AIDS) (Loxley et al., 1990). With the more recent

identification of another serious blood-borne virus, hepatitis

c. and its rapid

spread among the injecting drug using population, it has become more imperative
that preventive measures such as the sale of sterile injectbg equipment by
phannacists 11 be implemented with greater consistency and C<'Verage" (\Vodak &
Crofts, 1993, p. 18).

By early !994 the majority of pharmacies across the state (approximately 78%)
were selling needles and syringes to injecting drug users (Kerry, 1994). While this

couJd be regarded as a positive response to the government's initiatives there were
still a significant minority who did not supply. It was known that some nonselling pharmacists had never adopted this controversial practice, while others,
having undertaken it, had reversed their decision to sell (Greig, !992). There was

I

however, no good baseline data available concerning the factors that affected

supply practices nor of the attitudes of pharmacists in relation to this issue.
Neither was there any data avaiiable concerning the proportion of metropolitan
and country pharmacists supplying needles and syringes to injecting drug users in
Western Australia

While the supply of il\iecting equipment to illicit drug users was condoned for
public health reasons in Western Australia, it was technically illegal under section
36 of the Poisons Act 1964- Aiding and Abetting Drug Offences and section 6
(2) of the Misuse of Drugs Act 1981 -tu incite or conspire with another to
commit an offence (Keny, 1994). It was within this con\ext that this research was
planned with the question in mind of how the legal situation influenced
pharmacists' supply practices. At that time however, the Poisons Amendment Bill
1993 was expected to proceed to the third reading in the Legislative Assembly of
the Western Australian Parliament in March 1994, after which it was anticipated
the Act would be proclaimed, legalising the provision of needles Md syringes in

Western Australia under certain conditions (Kerry, 1994). There was no certainty
that the Bill would be passed as it had been rejected a number of times

previously. However, the outcome of the Parliamentary deliberations was that the
Bill was assented to on 15 April, 1994 by both houses of the Western Australian
State Government as the Poisons Amendment Act 1994 (amending the Poisons
Act 1964 and the Misuse of Drugs Act 1981) (Poisons Amendment Act, 1994)
and proclaimed on May 24, 1994 (Proclamations, 1994). This meant that by the

2

time data was collected for this study it was legal, with the approval of the
Commissioner of Health, to supply needles and syringes to injecting drug users.
Consequently the timing of this study is important because it was conducted ji.!St

after the legislation change and could determine whether the previous legal
situation, in the context of the lack of enforceroent, had impacted on supply
practices and offer some insight into whether the change in legislation would
make a difference in the future.

The Pul]lOse of the Study

This study was conducted to determine the attitudes and practices of Westem
Australian pharmacists regarding the supply of needles and syringes to injecting
drug users. The study was designed to establish the proportion of metropolitao
and country pharmacists currently supplying needles and syringes to injecting

drug users, the factors influencing current supply practices and factors that have
influenced supply practices over time. The type of information sought included
pharmacists' perceptions of the seriousness of HIV and hepatitis C as a public
health concern; their thoughts on the supply of needles and syringes to injecting
drug users; the policy and practice in their pharmacy regarding the sale of needles
and syringes and the factors influencing past, present and possible future supply
practices; and whether problems or difficulties had been encountered in their
pharmacy involving illicit drug users. Other information sought pertained to the
dispensing of methadone, pharmacists' understaoding of the legal status of
supplying needles and syringes to injecting drug users and the influence this had

3
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on supply practices, attitudes to injecting drug use and injecting drug users and
demographic details.

The Sh:nilicance of the Swdy

This research is significant because it is the first comprehensive study to be
C{)nducted in Western Australia to determine pharmacists' attitudes and practices
to the supply of needles and syringes to injectin£ drug users. The one small
unpublished study that surveyed pharmacists in relation to this issue was an
evaluation of the pharmacy 'Fitpack' program (Greig, 1992). Greig's (1992)
research, however, did not address the issue of the locality of pharmacists or their
atti~udes

to the provision of need1es and syringes to injecting drug users. The

results of the current study redresses a gap in knowledge and provides good
baseline data tha: could have implications for poliey and prc "\lee in regard to the
future supply of needles and syringes as well as other health initiatives.

A further significant feature of the study is that there has been no previous

research conducted which focuses on the beliefs and attitudes of phannacists in
reJation to hepatitis C, although several studies of a similar nature in other states
have concentrated on HJV (Cuatt, 1989; Jennings, 1987; Tsai, Gob, Webeck &
Mullins, 1987). Considering this, Western Australian pharmacists' perceptions of
the seriousness of hepatitis C is an important aspect of this study. The fmdings
should give some indication of the extent to which hepatitis C is understood and
will be of interest to health professionals and policy-makers alike.

4

Some phannacists experience problems and/or difficulties in conducting their
business with regard to the sale of needles and syringes to injecting drug users
(Greig, 1992; Monash Medical School, 1987). An important element of this

research is determining the extent to which pharmacists are experiencing problems
and difficulties and how they are handling incidents, and identifYing areas of
concern. Highlighting these factors may offer some insight into the need for
support and/or training for phannacists.

By supplying needles and syringes to injecting drug users phannacists are
providing a valuable service in the interest of public health. According to Lenton
( 1994) however, in the view of some phannacists:
there was little public acknowledgement of the work (they] have undertaken,
largely out of goodwill, in ntinimising the impact of HJV and other blood-

borne diseases on the community through participation in the scheme to
provide. [needles and syringes] to [injecting drug users]. (p. 3)

Therefore this research is significant for pharmacists who feel they have never
really been recognised for the service they are providing. Participation in this
project provides the opportunity for them to express their views and recount their
experiences in a formal manner, thus contributing valuable information to help
identifY key variables that could impact on policy or procedure that personally
effects them.

5

Researeh Questions

This study endeavours to answer three broad questions:
I. To what extent do pharmacists currentiy supply needles and syringes to
injecting drug users?
2. What are the factors that have influenced changes in the supply
practices of pharmacists?
3. What are the factors that differentiate between pharmacists who currently
supply of needles and syringes to injecting drug users and those who do not
supply?

Definition of Terrus

Injecting drug users In this study the term "injecting drug users 11 refers to persons
who inject drugs illicitly. It does not include persons injecting drugs for legitimate
health reasons, for example diabetics, unless specifically stated.

Hl!nn minimisation The National Drug Strategy Conunittee (1993) describes
harm minimisation as:
an approach that aims to reduce the adverse health, social and economic
consequences of alcohol and other drugs by minimising or limiting the
banns and hazards of drug use for both the community and the individual
without necessarily eliminating use. (p. 4)

The tenn 'harm minimisation' refers to the broad policy or approach and is
defined by Strang (1993?) as "the overall goal or endpoint to be aimed for" (p. 7).

6
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Hann reduction Harm reduction refers to the programmes and strategies
implemented to achieve the goals of harm minimisation (Strang, 1993?). For
example, supplying needles and syringes to injecting drug users is a harm
reduction strategy. Other strategies pertinent to the prevention of blood-borne
disease include educating injecting drug users of the potential danger of their

activities and ways to minimise their risk, and methadone programmes for opiate
dependent users.

Fitpack A Fitpack is a black plastic pack which holds five needles and syringes
providing a safe and convenient method of storing and carrying, frrst sterile, then
used needles which may be locked securely in place and the Fitpack safely
dispesed of.

Current SeUeJS Current sellers are pharmacists who were selling needles and
syringes to injecting drug users at the time data was collected for this survey.

Pll'lt selleJS Past sellers are pharmacists who had previously sold needles and
syringes to injecting drug users and no longer do so.

Never Sold The tenn 'never sold' refers to pharmacists who have never sold
needles and syringes to injecting drug users.

7

Nonsellem Nonsellers are phannacists who do not currently sell needles and
syringes to injecting drug users. They include past sellers and phannacists who

have never sold.

limitations of die Study
The timing of this study may be a limitation because it was conducted so soon

after the legislative change that removed the sanctions r~:garding the provision of
needles and syringes to injecting drug users. Some pbannacists were reacting to
having to apply for approval and may have been in a state of uncertainty about
their legal position (K. Keny, personal communication, October 1994) which may
have affected some of the responses received. Although it Wl<S known at the
planning stage that the change was highly probable it was hoped that the study

could have been conducted prior to the event or some months after. However, the
timing of the change and time constraints of the study prevented this.

As the total population of phannacists was not surveyed a further limitation of the
study is that there is no way of knowing whether the sample selected was

representative of all phannacists in Western Australia, thereby enabling accurate
generalisation. However, the random sampling technique and the high response
rate would indicate that this is not a serious limitation (de Vaus, 1991).

Self-report bias may also be a limitation. As de Vaus (1991) points out "responses

to sensitive or controversial questions can be affected by social desimbility

8

considerations: giving acceptable rather than true opinions" (p. 110). However,
according to Dillman ( 1978), of all self report type surveys mail surveys have the
least probability for socially desirable answers.

9

CHAPfER TWO

Review of Related Utemture

This review presents the background to the harm reduction strategy to supply
needles and syringes to injecting drug users, the Western Australian experience
and a review of previous Australian studies relating to pharmacists' supply of
needles and syringes. Firstly, an overview of the blood-borne diseases HIV/A!Ds
and hepatitis C is presented, followed by a discussion on injecting drug use.
Government po1icy in response to these diseases is described explaining hann
minimisation and hann reduction strategies, and more particularly the provision of
sterile injecting equipment to injectjng urug users. The Western Australian
experience is discussed particularly in relation to phannacists' role in needle and
syringe supply, and in the legal situation concerning supply. Deterrence theory,
which may be an influence on pharmacists' supply practices is also discussed.
This is followed by a discussion on attitudes to injecting drug users. The chapter

concludes with a review of previous Australian studies concerning pharmacists
supply of needle and syringes to injecting drug users.

10

Blood-bome Disease
AIDS
Since the first cases of AIDS in the western world were diagnosed in the United
States in 1981 a world wide health crisis has evolved due to the epidemic spread
of the disease, the phenomenon now being classed as a "global paodemic"
(National HIV/AIDS Strategy: 1993-94 to 1995-96, 1993, p. 5). The first

identified cases of AIDS were among men who have sex with men, believed to
have been transmitted through anal sex, with the first wave of the epidemic
spreading mpidly through the male homosexual/bisexual population in many
develofk.'<l countries of the world (Department of Community Services and Health,
1989).

Early in the epidemic it was recognised that injecting drug users were also
contracting HIV through sharing contaminated injecting equipment (Schuster,
i 992). A second wave epidemic among the injecting drug using population swept

through many countries including America, Europe and Asia (Des Jarlais, 1992;
Darke, 1992; Wodak, Crofts & Fisher, 1993). The experience of cities such as
New York (Des Jarbis & Friedman, 1990), Edinburgh (Robertson, 1990), Milan
(Tempesta & Gianntonio, 1990) and Manipur (Naik et al., 1991), with HIV

seroprevalence rates among injecting drug users increasing to over 50% in the
space of a few years, well illustrates the rapidity with which HIV can spread once
established within a population of drug injectors. Des Jarlais (1992) contends that

"a lack of AIDS awareness" among drug injectors &.. "1d "meci,anisms for efficient

11

mixing of the at-risk population" appear to be the most frequently identified
factor.; in the rapid spread of HIV (p. 34 7).

Because AIDS was fir.;t identified in the developed world among men who have
sex with men and among injecting drug users, it was initially assumed that

transmission was associated with male to male sex and with unsafe injecting
practiceo (National HIV/AIDS Strategy: 1993-94 to !995-96, 1993). However,

subsequent discovery of extensive heterosexual transmission of HIV in Afiica
changed this perspective and in recent years in the United States the proportion of
AIDS cases due to heterosexual contact has risen sharply (National HIV/AIDS
Strategy: 1993-94 to 1995-96, 1993).

In the western world injecting drug users are the "major conduit for the
dissemination ofHfl/ infection to the general community" (Wodak, 1990, p. 22)

by transmission from infected persons to their sexual partners, and perinatally
from mother to child (Kaldor, Elford, Wodak, Crofts and Kidd, 1993). This is
well illustrated in New York City where, by 1988, injecting drug users were the

source of infection in over 90% of heterosexual and over 80% of maternal~ infant
cases of AIDS (cited in Wodak, Crofts & Fisher, 1993). As Wodak (1990) points
out:

The control of HIV infection in the third wave of the AIDS epidemic - i.e.
in the non-drug using heterosexual community - will depend, in most

western

~untries,

on the success or failure of efforts to control the second

wave of the epidemic - i.e. the spread of HIV in injecting drug users. (p. 22)

12

Prevalence of HIV/AIDS in Austmlia.
From the time AIDS was frrst recognised in Australia il' 1982
until June 30, 1994 according to figures from

th'~

(Wodal~

1992)

Australian HIV Surveillance

Rewrt (National Centre in Epidemiology and Clinical Research, 1994a), a
cumulative total of 18,274 diagnosed cases ofHIV infection were officially
reported. Of these 4,882 had developed into AIDS. Eighty one percent of cases
were reported to have been contracted through male homosexual/bisexual contact,
5.2% through injecting drug use, and a further 2.9% of cases were among

homosexuaVbisexual males who also injected drugs. Over the years an increasing
number of heterosexnals have contracted the virus with only 1.3% of total cases
reported up to 1985 compared with 14.2% during 1993 (National Centre in
Epidemiology and Clinical Research, l994b). The proportion of reported cases
associated with injecting drug use in 1993 was 4.7%.

New South Wales, the state in which HIVIAIDS was first diagnosed

(Wod~

1992), has the highest prevalence ofHlV/AIDS with 63% of cumulative cases
reported to December 31, 1993 (National Centre in Epidemiology and Clinical
Research, l994b). This figure reflects the fact noted by Tsai, Gob, Webeck and
Mullins (1988) that while New South Wales has approximately one third of the
Australian population it b'IS an estimated 50% of the total intravenous heroin
users in Australia. Another factor in the high proportion of HIV in New South
Wales is the substantial homosexual community in the state, particularly in
Sydney, which has an identifiable gay district in the inner city

(Wod~

1992).

l3

Following New South Wales, Victoria with approximately one quarter of the
Australian population (Castles, 1993) has 19"/o of cumulative cases ofHN,
Queensland with 17% of the population has 9% of cumulative HIV cases and
Western Australia with one tenth of the population has 4% of cumulative cases of
HIV. The other states and territories have less cases of HIV in proportion to their
population.

Prevalence of HIV/AIDS in Western Australia.
Figures from the Epidemiology and Health Statistics Section of the Health
Department of Western Australia reveal that since the first cases were recognised
in this state in 1983, there have been 823 notifications ofHN until March 1994,
155 of which have developed into AIDS (M. Ashwell, personal communication,
March 18, 1994). Of all cumulative HIV cases 73.5% were among homosexual

and bisexual men. Another 5.9% were associated with injecting drug use as a
single risk factor (4.1% being males and 1.8% females) which increased to 12.1%

when men who

h~ve

sex with men were taken into account. ;\{eterosexual

transmission of the virus accounted for 8.8% of cases.

Prevalence of HIV/AIDS amo112 injecting drug use111.
As previously mentioned the incidence ofHIV/AIDS among drug injectors is over
50% in some overseas cities. In eddition to this, Des Jarlais (1992) notes that drug
injectors are the largest single group of persons with HIV/AIDS in many cities
and countries, including New Jersey and Connecticut in the United States,

14

Edinburgh in Scotland, Spain, Italy, Thailand and China In comparison, in a
review of twelve Australian studies which measured the prevalence of HIV
infection among injecting drug users Kaldor, Elford, Wodak, Crofts, & Kidd
(1993) foWld that HIV seroprevalence among this population has been low, at 0

to 5%. However, among male injecting drug users who also had sex with men
HIV prevalence ranged from 20% to 24%. In a Perth study Loxley, Marsh,
Hawks, & Quigley (1992) found the prevalence ofHIV in a sample of Western
Australian injecting drug users was quite low with 2.2% of the participants testing
positive for the HIV antibody.

Wodak (1992) claims that while the number of AIDS cases in Australia are
relatively low compared to many other parts of the world, possibly due to the

initiatives of the government in relation to the prevention of the disease, we
cannot become complacent. The National Evaluation Steering Committee (1992)
agrees and asserts that:
effort needs to be kept up to maintain adequate levels of safe bohaviour in
the long term - the epidemic is still young and unstable and the potential for
renewed rapid spread still exists. To do otherwise would be hazardous. (p.
9)

Hepatitis C
Another serious blood borne-virus, Hepatitis C which affects the liver, was
identified in 1989 (Frankis, 1994) and is also reaching epidemic proportions,
particularly among injecting drug users. According to the Australian
Gastroenterology Institute (1994) hepatitis C is responsible for at l<HSl 95% of
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cases of chronic Non-A Non-B hepatitis. More than 50% of individuals exposed

to the virus become chronic carriers with at least 25% of cases developing into
chronic liver damage, resulting in cirrhosis and in some cases liver cancer.

The most efficient transmission of hepatitis C is by blood to blood contact, and
less efficiently sexually (Crofts, et a1., 1993., Australian Gastroenterology
Institute, 1994). Current information from the Australian Gastroenterology
Institute (1994) reveals that in Australia, of patients infected with hepatitis C,
about 60% have acquired the infection by shatiug contaminated injecting
equipment during drug use and another 25% from transfusion of blood or blood
products prior to February 1990. However the incidence of sexual transmission

from a person with chronic hepatitis C infection appears to be low and much rarer
than for HIV and hepatitis B although there are indications that persons with
acute hepatitis C may be more likely to transmit the disease sexually.

Prevalence of hepatitis C

It has been estimated that there are 500 million people infected with hepatitis C
around the globe, with estimates in Australia varying between 80,000 and
200,000, according to Frankis (1994). This represents a far greater prevalence of
hepatitis C than HJV and Wodak and Crofts (1993) report estimates of at least
five times more people infected with hepatitis C in Australia than there are
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ilifected with HIV. Moreover, there are at least 15 times more new infections of
hepatitis C each year compared to HIV.

The Australian Gastroenterology Institute (1994, p. 3) reports that among overtly
healthy Au•tralian blood donors, the hepatitis C viral canier rate is 0.2% - 0.4%.
However, it is noted that due to the screening of those blood donors at special
risk of hepatitis C, prevalence may be higher in the general population. It is
however, the iqjecting drug using population that is most affected by hepatitis C
in Australia, with history of past or present injecting drug use being the
commonest risk factor for contracting the virus (Kaldor et a!, 1992; Wodak &
Crofts, 1993). For persons who have ever injected drugs the risk is 70%,
increasing to 90% amongst those using drugs intravenously for more than two
years at an earlier stage in their lives (Australian Gastroenterology Institute,
1994).

Studies in other developed countries (cited in Crofts et al. 1993) have shown
hepatitis C seroprevalence rates among injecting drug users of 500/o to 80%. In
Australia, a Victorian cohort study conducted by Crofts and his colleagues (Crofts
et al., 1993) found that 68% of injecting drug users were infocted with hepatitis
C, risk being particularly associated with length of injecting. In an earlier study in
New South Wales, Bell and his associates had reported an even higher incidence
of hepatitis C among a sample of injecting drug users with 86% of subjects
testing positive (Bell et al., 1990). In this study it was found that approximately
17

two thirds of injecting drug users became hepatitis C positive within two years of

commencing regular intravenous drug use with 100% seropositivity among
persons injecting drugs for more than eight years. As Bell and his associates (Bell
et al., !990) point out, these figures indicate that youog people who experiment
with illicit drugs are at significant risk of contracting hepatitis C.

Prevalence of hepatitis C in Western Austmlia.
Estimations have been made that between 10,000 and as many as 30,000 people
in Western Australia may be infected with hepatitis C, with prosent and former
injecting drug users, hlood product recipients, "'d migrants who had shared·
needle immunisations overseas being the main groups affected (Treweek, 1994).
While hepatitis C only became a notifiable disease in Marct 1993 in Western
Australia, a total of 1526 cases were reported by April 20 1994 (Treweek, 1994).
Of clients tested in the Perth methadone clinic 85% to 90% tested positive for
hepatitis C (Kerry, 1994) indicating that the incidence of hepatitis C in the
injecting drug using population in Western Australia is extremely high.

While transmission of hepatitis C is similar to HIV, Hulse, Moore and Lambert
(1993) assert that due to the low incidence ofHIV in Australian injecting drug
users the risk of infection during any single needle sharing incident remains
relatively low. Conversely, with the high incidence of hepatitis C among persons
injecting for longer that four years, "the likelihood that hepatitis C transmission
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and infection will result from a single sharing of injecting equipment is extremely
high" (p. 635).

Although the incidence of HIV among people with a history of injecting drug use
relllllins low, it is rising gradually (Kerry, 19Q4). Furthermore, with the prevalence
of hepatitis C within the Western Australian injecting drug using population
"alarmingly high" (Donoghoe, 1994, p. 31) it is clear that measures to prevent
transmission of these blood-borne diseases should continue to be supported and
developed.

Injecting Drng Use
While it is difficult to accurately assess the prevalence of injecting drug use it

appears there are an increasing number of injecting drug users in Australia. For
example, by extrapolating from the findings of a national household survey
conducted in 1986-87 Spooner (1988) estimated that the number of adult injecting
drug users at that time was 172,000. More recent figures from the
Intergovermnental Committee on AIDS (1992) estimated there were 200,000
injecting drug users in Austr•Jia. According to Crofts and Wodak (1993}, in 1993
an estimated 200,000 people (representing 2.4% of the adult population) had
injected drugs at least once in the previous 12 months. Crofts and Wodak (1993)
further report that an exponential increase in the drug related crime rate during the
1980's in Australia suggested a rapid increase in the number of people injecting
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drugs with a possible average recruitment of 10'/o, with 5% leaving the injecting
drug using population ann••ally.

Numbers for people injecting drugs in Western Australia have been estimated at
2,500 to 5,000 regular and 10,000 to 12,000 recreational irtiecting drug users
(Schwartzkoff and Watchirs, 1991). Researchers have been cautious about making
estimates of prevalence over more recent years in Western Australia but indirect

drug use measures tend to suggest it is increasil. ~ (Lenton, 1993).

One possible explanation for the growing number of injecting drug users in
Australia is that since the mid 1980s the prevalence of amphetamine use has
clilnbed (Reilly & Home!, 1988) with a resulting increase in the number of drug
users choosing injection as the mode of administration (Aisbett, 1991; Hall &
Hando, 1993, Hando & Hall, 1994). Spooner, Flaherty and Home! (1993)
confirmed this trend when they found that, of a street intercept sample of young
Sydney illicit

dm~

users, amphetamines were the most commonly used illicit drug

after marijuana with 61% of the sample having used amphetamines in the
previous three months, one third of whom had injected the drug. According to
Lenton (1993), from 1991 to 1993 amphetamine use became more prevalent
nationally among the 20 to 25 year age group, particularly males and in Western
Australia indirect measures, including arrest and seizure data, suggest
amphetamine use has increased over recent years. Indeed, three years ago in
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Western Australia fears were expressed in the media of the possibility of an
increase in the spread of HIV due to the upsurge in amphetamine use among
young people (Aishett, 1991). More recently the Western Australian Director of

Public Prosecutions issued warnings that Perth was "awash with amphetamines"
(cited in Lang, 1995, p. I).

The cost of street drugs and their impurity is also a principal factor in the number
of drug users injecting drugs rather thllil using alternative routes of administration
(Wodak, 1989). In places where drugs are less expensive and of higher purity

users will also sometimes inhale or ingest their drugs. This is the case in
Amsterdam where it is estimated that at least 60% of heroin and cocaine users do
not inject but inhale, or 'chase the dragon' (Buning, van Brussel & van Santen,
1992). With the increasing prevalence of persons injecting drugs in Australia the
potential to further fuel the HIV/AIDS and hepatitis C epidemics, through unsafe
practices, is enhanced.

Needle Sbarine
While injecting drug use is not in itself a risk factor in the spread of AIDS and
hepatitis C the sharing of contaminated injecting equipment is. The extent to
which injecting drug users share needles and syringes are dependent upon a
number of factors. Studies have found that the most common reason given for
sharing has been the difficulty in obtaining new equipment (Australian National
AIDS and Injecting Drug Use Study (ANAIDUS), !992; Edgoose & Baillie,
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1987; Ingold & Ingold, 1989; Lmdey et al, 1992). The social context of drug use
(ANAIDUS, 1992) and broad social nonns within the drug culture such as
neighbourliness and mutual support also influence needle sharing (McKeganey &
Barnard, 1992). Laws regulating the sale and possession of needles and syringes
also effect needle sharing practices (Tsai et al., 1988; Anderson, 1991). Other
reasons given for sharing include unavailability of clean equipment at times of
urgency or desperation (ANAIDUS, 1992; Ingold & Ingold, 1989) and lack of
motivation to obtain new equipment

(Edgo~>se

& Baillie, 1987).

McKeganey and Barnard (1992) and Loxley et al (1992) found that most needle
sharing involves sexual partners, close friends or family members who are
considered 'safe'. It appears that women injectors, who tend to have injecting
partners (Kiee, 1993), may be more vulnerable to risk of infection with HIV and
hepatitis C than their male counterparts, through sexual transmission and the more
frequent sharing of their partner's used equipment (Barnard, 1993; Klee, 1993).
Considering this, the possibility of further transmission to unborn infants is

increased.

Studies reveal a decrease in HIV risk behaviour; among injecting drug users, by
either no longer injecting or reducing the incidence of equipment sharing
(ANAIDUS, 1992; Loxley et al, 1992; Power, Hartnoll & Daviaud, 1988; Ronald,
Roberton & Roberts, 1992; Ross, Stowe, Wodak & Gold, 1993; Saxon, Calsyn &
Jackson, 1994). However, as Wodak (cited in Loxley et a!, 1992) points out:
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although there are consistent local and international reports of reductions in

unsafe injecting, and to a lesser extent sexual, practices, the baseline levels
of these behaviours is very high, and relapse to HIV-related risk behaviour
is increasingly recognised as a problem. (p. 691)

In Perth, Western Australia, results of the ANAIDUS study conducted by Loxley
and her colleagues (Loxley et al, 1992) revealed that while respondents reduced
their unsafe injecting to some extent, their needle sharing behaviour still placed
them at a high level of risk of HIV. As there is a greater possibility of contracting
hepatitis C than HIV in Australia these iryecting drug users are at even greater

risk of contracting a serious blood-borne disease.

Public Policy
Australia's response to the threat of the HIVIAIDS epidemic was led first by the
homosexual community, followed by federal and state governments and other

communities, leading to the development of a range of comprehensive policies
culminating in the National AIDS Strategy (National Evaluation Steering
Committee, 1992). One of the earliest committees formed was the National
Advisory Committee on AIDS (NACAIDS) which was set up in 1984 to advise
on educational, legal and social issues related to the epidemic and which made a
substantial contribution to early education and allaying the public's fears about
HIV/AIDS. From 1984 to 1987 the National AIDS Task Force was the guiding
medical and scientific organisation. These two bodies were replaced in 1988 by
the Australian National Council on AIDS. As the National Evaluation Steering
Committee (!992) points out, Australia's response to HIV/AIDS has been
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characterised by "strong national leadership and political commitment" (p, 19)
with this country being one of the few countries to have a National HIVIAIDS
Strategy .

Harm Minimisation
In view of the incurable nature of HIV/AIDS the federal government in Australia

adopted a prevention approach to the transmission of the disease. A critical factor
in this response was the National Campaign Against Drug Abuse in 1986 with its
principle aim "to reduce the harmful effects of drugs on A11stralian society"
(Biewett, !987). The principle of harm ntinimisation recognises that there is a
broad spectrum of levels of drug use, acute and chronic, and of associated risks
and physical harm (National Drug Strategy Cornntittee for the Ministerial Council
on Drug Strategy, 1993). People everywhere use drugs of one kind or another for

different reasons, and most drugs can be used in ways that are safe or ways that
are harmful, and also in ways that are deadly ("Harm reduction", 1991), With this

in mind the concept of harm reduction was perceived as a more realistic aim than
the unachievable goal of a drug free society (Wodak, 1992). There was also a
growing belief throughout the 1980s that a hann minimisation approach was more
realistic than the more rigid medically based ideas of "treatment', "cure" and
"abstinence" (Berridge, 1990, p. 343) which had previously dontinated.

While not abandoning the old strategies new ones emerged in response to more
enlightened ;:md realistic thinking about drug use, For example Prochaska and
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DiCiemente (1986) suggested that drug users go through a number of stages in
the process of change. These included precontemplation (when persons are not
contemplating change and are resistant to it), contemplation (thinking about
changing and weighing up the pros and cons of continued using and abstaining),
action (taking action to stop using) and maintenance (maintainir1g change and
preventing relapse). More recently another stage, preparation (intending to change
in the near future), has been included between contemplation and action
(Prochaska, DiCJemente & Norcross, 1992). An individual may move forward or
relapse to a fonner stage. The previous ideas of treatment, cure and abstinence are
useful strategies for persons who are in the action and maintenance stages of

change. Precontemplaters, however, don't want to change; contemplaters are
ambiva1ent about it; and preparers are not quite ready. so it is for these

individuals that harm reduction strategies may be most appropriate.

Moreover, the phenomenon of natural remission from drug dependence and

addiction was becoming increasingly recognized (Peele, 1989). In the case of
heroin Winick (cited in Peele, 1989) had found as early as the 1960s that most
adolescent and young adult heroin addicts in New York outgrew their addiction
by their mid-thirties. More recently Stimson and his colleagues (Stimson,
Oppenheimer & Thorley, 1978) found in a follow-up study of heroin 'addicts'
known to have attended London drug dependence clinics seven to eight years
earlier that at least 40 people out of the original cohort of 128 had achieved
abstinence, the large majority having no treatment after withdrawal. This maturing
25

out, as the phenomenon has become known, demonstrates the human potential for
change and "provide[s] an antidote to long-indoctrinated images of the everdeepening spiral of heroin addiction" (Peele, 1989, p. 176). Waldorf ( 1983) too,
could see the possibility for change and declared that dependent users or 'addicts'
(especially heroin 'addicts') are caught in a pattern of abstinence and relapse, that
ends up in either death or a stable, drug free life. By minimising the harm
associated with the use of drugs, individuals are helped through a phase in their
lives and have the chance to hopefully overcome their drug use in the future
through either treattnent or natural recovery (Waldorf, 1983) without contracting a
life-threatening disease.

With the advent of IDV and hepatitis C the potential dangers of injecting drugs
were enhanced markedly, in light of the deadly nature of the diseases.
By introducing harm reduction strategies to help prevent infection with these

viruses, injecting drug users may live long enough to stabilize their lives. For as
Dave Purchase, the Director of an illegal needle exchange in Tacoma, Washington
in the United States said in relation to HIVIAIDS and injecting drug use: "you

can overcome being stupid, but you can't overcome being dead" (cited in "Harm
Reduction Conference", 1992, p. 21 ).

Furthennore, it was recognised that there were a :mbstantial number of nondependent drug users in the community (Spooner, 1988) who were at potential
risk of contracting and transmitting disease to others. In outlining some of the
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characteristics of the injecting drug using population Spooner (1988) categorised
these users as dependent users; non-dependent regular users; and non-dependent

rt."Creational, occasional and experimental users and suggests that the non·
dependent users represent a much larger proportion of the total of injecting drug

users. Moreover. individuals were known to move between categories and
between using and non-using status. Although the incidence of HIV among
dependent users may be greater, the non-dependent group being numerically
larger possibly have the greater potential for viral transntission (Spooner, 1988).

All of these factors, plus the increasing concern of health workers and the general
public over the spread of AIDS which was a major impetus to the decision to
adopt a harm minimisation policy (Luger & Batey, 1993), have impacted on the
adoption and acceptance of the pragroatic approach of the Australian Government
towards the prevention of HIV/AIDS and hepatitis C. And, as Luger and Batey
(1993) add, "few would have problems accepting the notion that substance users

should be spared serious, destructive consequences associated with their activities''
(p. 3).

Bann Reductio• Stmtegies.

In the realm of HI V/AIDS, harm ntinimisation took two forms, education and

prevention, in an effort to eliminate transmission of the virus (Department of
Comrnuoity Services and Health, 1989). Education was targeted to specific groups
which included penple whose activities placed them at greater risk of infection -
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and those affected - including homosexual/bisexual males and injecting drug
users; carers of people with HIV including professional care givers; and the
general community. Safer sexual practices were advocated which included
alternatives to intercourse and the use of condoms. In relation to the injection of

drugs, strategies for avoiding unsafe drug use involving contaminated injecting
~uipment

were promoted. A hierarchy of messages was aimed at various

injecting drug using audiences. These includ •d: preferably, don't use drugs; if you
must use, don't inject; if you must inject, don't share; if you can't help sharing,
clean your needles with bleach (Loxley, Marsh, Westlund and Watson & Kosky,
1990). To discourage sharing of injecting equipment needle and syringe
distribution and disposal programs were initiated which entailed tlle
implementation of needle exchange and outreach programs, the sale of sterile
injecting equipment through pharmacies and the introduction of needle vending
machines. Injecting drug users \'.'ere encouraged to clean used injecting equipment

with the use of bleach, if they were to be re-used. Furthermore drug substitution
programs were expanded, relaxing the previous strict criteria for entry, to enable
persons access to oral methadone as a substitute to injection of heroin, thus
reducing the number of injecting drug users and the consequent hann associated

with this mode of administration (Wodak, 1990; National Methadone Policy,
1993). As Cuatt (1989) notes, by educating injecting drug users of the potential
danger of HIV infection through unsafe practices and making sterile injecting
equipment widely available and accessible, it was reasonable to assume that
needle sharing behaviour would decrease.
28
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Needle and Syringe Supply

As a result of the governments' prevention strategies, since 1986 in Australia
sterile injecting equipment has been made available to injecting drug users.
Needle exchange programs, outreach vans and vending machines have been
introduced in locations where there are significant nwnbers of injecting drug users
(Crofts, 1992; Dodding, 1993?; Dolan, 1989; Loxley et al, 1990; "IV drug users,"
1989). In addition, pharmacists have been encouraged to sell sterile injecting
equipment to injecting drug users, thereby assuring availability in both
metropolitan and rural areas. The Pharmacy Guild of Australia and the
Pharmaceutical Society of Australia supported the strategy but left the decision to
supply needles and syringes to drug users to the professional judgement and
discretion of individual pharmacists (Cuatt, 1989; Tsai et al, 1988).

Western Austrnlian Initiatives
In Western Australia a harm minimisation policy was adopted and promoted by
the Health Department of Western Australia and the AIDS Council with the

hierarchy of messages being promoted to various injecting drug using audiences.
In late 1986 a decision was made by the Health Department of Western Australia
to promote the sale of sterile injecting equipment to injecting drug users by
pharmacists, who were seen to be "accessible, strategically placed, already selling
needles and syringes to diabetics and had a legitimate role in health care" (Loxley
et al, 1990, p. 14).
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Under the joint auspices of the Health Department of Western. Australia and the
Ph· :maceutical Council the SS5 Kit Pharmacy Program was established in July
1987 (Kerry, 1994). The SS5 Packs, consisting of a plastic bag containing one
sterile needle and syringe, a swab, condom, lubricant, a rigid disposal r-<>ntainer
and an information pamphlet were supplied by the AIDS Bureau free to
pharmacists, who added four needles and syringes and sold them at • profit By
1990 56% of metropolitan and 25% of counby pharmacies were participating in
the program (Swensen, Westlund & Baker, 1992). In July 1992 the Pharmacy
Fitpack Program replaced the SS5 Kit Pharmacy Program (Kerry, 1994). Fitpacks
are a specially designed black plastic pack which holds five needles and syringes.
The packs are designed to provide a safe and convenient method of storing and
carrying frrst sterile, then used needles which may be locked securely in place and
the Fitpack disposed of in a public waste disposal bin. The Pharmacy Fitpack
Program was initially subsidised by the Health Department of Western Australia,

but since 1992 it has been a commercial operation for pharmacists who now deal
with wholesalers directly to replenish their supplies (Kerry, 1994). Figures from

order forms indicate that approximately 78% of Western Australian pharmacies
are currently involved in the sale of Fitpacks (Kerry, 1994).

Thel.aw
In almost all developed countries legal access to sterile injecting equipment has
been a primary public health approach to help prevent the transmission of HIV
among injecting drug users (Des Jarlais & Friedruan, 1992). The most notable
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exception is the UnitOd States where this strategy has remained highly
controversial with only a few localities adopting it. Des Jarlais and Friedman
(1992) note that opponents of legal access to injecting equipment in the United
States have argued that such a strategy would "not work to reduce H!V

transmission". would 11 encomage" or "condone" illicit drug use, would "send the
wrong message" and would "undermine our war on drugs" (p. 45). In New York
City in particular, proposals for the distribution of clean injecting equipment to
drug users have provoked vehement opposition (Anderson , 1991). The
abandonment of a needle exchange trial in New York was due to social and

politica1 resistance. Even clear evidence from overseas that tlJe provision of
needles and syringes reduced needle sharing without increasing addiction, "was
outweighed by the policy's symbolic affront to social order" (Anderson, 1991, p.
1515).

In Australia, at the time the policy to supply needles and syringes to persons who
injected drugs illicitly was first implemented, it was an Aiding and Abening
offence under the Criminal Code in most States and Territories (Schwartzkoff &
Watchirs, 1991). Some Slate Governments amended legislation almost
inunediately to indemnifY pharmacists and needle exchange workers from

prosecuticm. In other States, incJuding Western Australia, agreements were
reached bdween State Health Departments, AIDS Councils and the police to
enable the distribution of sterile injecting equipment, while lobbying for
legislative change. Western Australia was the last state to have legislation
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am, Jed to remove legal restrictions from the distribution of needles and
syringes, although supply has been unofficially condoned and implemented since
1987.

As previously discussed, it ·vas still illegal to provide needles and syringes to
iqjecting drug users in Western Australia at the outset of this research endeavour.
Legal sanctions were removed, however, when the Poisons Amendment Act 1994
was proclaimed on May 24, 1994 making it legal in Western Australia, for

persons gaining the approval of the Commissioner of Health, to prov.Je needles
and syringes to injecting drug users. A special edition of the Western Australian
Government Gazette on May 26, 1994 outlined the regulations, duties and

requirements of persons engaged in the provision of needles and syringes and
included a copy of the application for approval required to conduct such
programmes (Poisons Amendment Regulations 1994 ). Copies of the Poisons
Amendment Act 1994, the special edition of the Government Gazette and a
Poisons Act 1964 Form 14, Application for approval of needle and syringe
program (see Appendix A), were pnsted to all Western Australian community
pharmacists and needle exchange operators (K. Kerry, personal commurtication,
October 6, 1994 ). Concerns were expressed by some pharmacists in relation to
having to gain approval for an activity they had been involved in for some time in
the public interest, and the fact that they were expected to submit yearly reports
(K. Kerry, personal communication, August 20, 1994). In light of the concerns

exoressed, the Pharmaceutical Council of Western Australia negotiated with the
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government to enable the Council to gain a blanket approval for all pharmacists.
On September 5, 1994 the Pharmaceutical Services Branch of the Health

Department of Western Australia granted permission to the Pharmaceutical
Council to coordinate the program for blanket approval for pharmacists to sell
Fitpacks only for a term of 12 months (B. Fry, personal communication, January
19, 1995). The sale of needles and syringes to injecting drug users in other forms
required the pharmacists to personally apply for approval to do so.

Although supplying needles and syringes to injecting drug users was illegal
(although condoned) in Western Australia until May 1994 an increasing number
of pharmacists were providing them. Between 1990, when 44% of pharmacists
overall were involved in the SS5 Pack Program (Swensen et al, 1992) and 1994 a
further 34% had adopted the practice. 1t is apparent that the majority of
pharmacists were not deterred by the legislation but some still did not supply and

the reasons for this were not known. Neither was there any infonnation available
concerning the reasons for the change in pharmacy policy of those who have
adopted the practice.

Deterrence Theoty

Deterrence theory is based on the premise that 11 the more the individual perceives
legaJ sanctions as certain, swift and/or severe, the greater is the perceived cost of
crime and thus the probability of deterrence" (Williarns & Hawkins, 1986, p.
547). According to Home! (1988) certainty of punishment is historically
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regarded as the most important of these variables rather than the mere existenCe
of legal sanctions. Home! explains that the argument for deterrence as a tool for
social control is based on the premise that the behaviour of humans can be
modified by making them fearful of the consequences of committing illegal acts.
In the words ofGibbs (cited in Home!, 1988): "Deterrence can be thought of as

the omission of an act as a response to a perceived risk and fear of punishment
for controry behaviour" (p. 22).

The classic example of deterrence theory most often quoted is that of the
effectiveness of Random Breath Testing (RBT) in New South Wales where there
is a high probability of drivers being stopped and breathalysed and penalties for
drink drivers are certain, swift and severe (Home!, 1988). A more recent example
of the application of deterrence theory is reported by Woods ( 1995) and relates to
the sale of tobacco products to persons under 18 years of age in Western
Australia Although being illegal since 1917 the activity was widespread, penalties
were small ($4 for a first offence) and no prosecutions were recorded. The
passing of the Tobacco Control Act 1990 increased penalties for sale of tobacco
products to persons under 18 to $5,000 for individuals and $20,000 for corporate
bodies for a first offence. A study conducted 14 months after the law came into
effect found that this alone was not enough to deter the majority (89%) of tobacco
retailers (cited in Wood, 1995). Based on deterrence theory principles the Health
Department of Western Australia devised and applied "the 3 Ps of prosecution,
publicity ond persuasion" (Wood, 1995, p. 8). This resulted in mnch publicised
34

_,, ___ ,

•_---,--~--·.:··:--~_,..-,..._.-~-.-.-~~-:-;~-~~-...,.,-"0---'"""~~~-·~»·•----·----____ _

prosecutions with penalties rangUig consistently between $500 and $1 ,000 plus
court costs. Within two years a further study showed that the percentage of
retailers prepared to sell tobacco products to minors had dropped dramatically by
6lo/oto 28%.

Although the sale of needles and syringes to injecting drug users was illegal in
Western Australia there was an unwritten agreement that it would not be enforced.
It was considered useful to use this study to determine whether the legal status in

this context had any effect on needle and syringe supply. If deterrence theory is
correct then mere legislation would not deter.

AUitudes tn lnjeding Drug Users
According to Wodak (!992) the prevailing public image of drug users in the mid
1980s was of "psychopathic demons" (p. 557). However, within a few years this
image had modified with increasing attention directed to the complex nature of
drug use and the deficiencies in the treatment system, so that rather than being
seen as "archetypal villains" injecting drug users were seen, in part, as victims.

As Wodak points out "without this change in image, it would not have been
possible to generate public support for some of the more controversial measures
required to control HIV infection in this risk group" (p. 557).

While Wodak (!992) contends that injecting drug users "are still demonised to
some extent in Australia" (p. 557) MacCarthey (1994) claims that discrimination
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ag•ainst injecting drug users is widespread. In an article in the National AIDS
Bulletin MacCarthey (1994) asserts that "the concept of discrimination is based on
fairness .... [the principle of which) ... does not apply to groups that are perceived
to make lifestyle choices" (p. 32). Therefore society generally justifies
discriminating against injecting drug users as injecting drug use is seen only as a
lifestyle choice and, at some time in an injector's life, a decision to inject was
made. Other factors at play that may help explain the extent 0f discrimination
against injecting drug users are listed by MacCarthey as: the illegality of the
drugs and most associated behaviours; injectors being considered criminals unlike
other law breakers who may speed, litter, cheat on taxes etc; views of injecting
drug users coming more from moralistic and often incorrect information rather
than from accurate research/facts; and negative and emotive media portrayal of
injecting drug users. According to MacCarthey, one of ways that discrimination
manifests itself is in the poor response injecting drug users generally experience
to a wide range of services.

In a British study of general practitioners Abed and Neira-Munoz (1990) found
that the majority of general practitioners believed that drug users were deceitful,
unreliable and uncooperative patients, that their problems were of their own
making and that drug dependence was not a medical problem. On the other hand,
only about one third of general practitioners saw drug dependence as morally
wrong. Abed and Neira-Munoz (1990) stressed that although their study, and that
ofGianz (cited in Abed & Neira-Munoz, 1990), highlighted definite negative
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attitudes towards drug dependents some positive attitudes were also demonstrated,
particularly by younger general practitioners who were more prepared to take an
active part in their management.

Although MacCarthey (1994) claims widespread discrimination of injecting drug
users in Australia it appears that Wodak's (1992) assertions of a moderation in
image may have occurred among the pharmacists' fraternity, considering the
adoption of the governments' harm reduction initiatives by pharmacists. However,
it is not known what the attitudes of pharmacists in Western Australia are towards
injecting drug users, or to what extent this impacts on the supply of sterile
injecting equipment to injecting drug users.

Previous Australian Studies
A literature search has located nine previous Australian studies, including two

from Western Australia, relating to the supply of needles and syringes by
pharmacists to injecting drug users. The purpose of the studies differed slightly
and focused on a number of research questions ranging from attitudes of

pharmacists regarding the provision of needles and syringes to injecting drug
users to evaluations of the programs that supplied packs of needles and syringes.
Both Western Australian studies were evaluations of the needle-pack program
current at the time. A variety of sampling procedures and data collection methods
were used. A summary of the studies and their characteristics are outlined in

Table I with the main findings presented in the following section.
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Table 1
Review of Australian Stu!Jies

Year

State

Guastclla. R. &. Roller, L.
Victorian College ofPhllnltacy

1986

Victoria

Jennings, G.

1987

Author

Area
Me!ro

Sample

Response
Rate

Random Sample

9.5"/o

Selling

Method
Interview Schedule

N=38

Victoria

Health Promotions, Victoria

10 Rural
Cities

All Phannacists
N=85

Practice
C/S
NJS

96.50%

Telephone Interview
Prc·postcd schedule

CIS
NIS

PIS
Monash Medical School

1987

Victoria

Motro

86.40%

Interview Schedule

1987

NSW

Metro&
Country

Stratified Random
Sample N=llO

96%

Telephone Qucstiormairc

Mullins. R. M.

1989

Victoria

Motro&
Country

All Victorian
Community
Phannacists

38%

Mail Questiormaire

Pharmacy Guild
members N"" 150

48%

CUatt, L.

1989

Tasmania

Tasmanian AIDS Council

WA

Swcnsen, Wcstlund & Baker
Health Department ofWA

1990

MSJ Keyes Young
NSW AIDS Bureau

1991

NSW

Greig. R.
WA AIDS Bureau

1992

WA

Whole
slate

Mail Questionnaire

Study of order fonns for
the SS5 Pack

Whole

""'
Metro &
Cournry

CIS

NIS
PIS

Tsai, Goh, Wcbcck & Mullins
Epidemiology, Health Dcpl NSW

HcaiUt Promotions Unit
Health Dept. Victoria

w

Systematic Sample
N=:96

Melbourne. Victoria

PU!posivc Sample
N=80

58%

Mail Questionnaire

Purposive Sample

97.40%

Telephone Interview

N=114

Note. C/S =CUrrent sellers; PIS::: past sellers; N/S =never sold; N&S =needles am syringes; ID Us::: injecting drug users.

36%
64%

Attitudes to selling N&S to IDUs.

63%
32%
5%

Attitudes on AIDS and lbe
availability ofN&s to IDUs.

45%
46%

Attitudes and practices In relation
to the sale ofN&S to IDUs.

.....

Attituries towards existing N&S
distribution and needle cxclmngc
progrmffi and role in educating dients.
CIS
NIS

PIS

29%
26%
14%

CIS

32%

NJS

68%

44%
CIS
Metro 56%
Country25%

Phannacists willingness to participate
in initiatives to increase saJes.

Attitudes and practices of pharmacists
regarding lhc sale ofN&s to IDUs.
Evaluation ofSS5 Pack Program.

Evaluation of the Fitpack Program.

CIS
NIS

PIS

00

Research Question

86%
10%
5%

Evaluation of the Fitpack Progrwn

Phannacisls' Pereeptions of the Seriousness of IiivtAIDS
Pnblic health.
Indications are that the majority of Australian pharmacists recognise the serious
implicaticns of HIV/AIDS. In a Melbourne study, when asked to list the three
most important health problems facing Australia, pharmacists gave an
overwhelming priority to AIDS, which accounted for 51% of first mentions and
26% of all mentions (Monash Medical School, 1988). The researchers commented

that even allowing for thf; respondents' awareness that AIDS was the main topic
of the study, it was clear Melbourne pharmacists did not underestimate the gravity
of the HIV epidemic. However, results from Jennings (1987) study revealed that
fewer Victorian rnral pharmacists (46.4%) saw AIDS as a major public health
issue in Victoria A similar result was elicited by Cuatt (1989) in Tasmania where
43% of pharmacists perceived AIDS to be a serious or reasonably serious public
health risk.

lnjectim: dl!ll: use...

A higher proportion of pharmacists believed injecting drug users to be at greater
risk of AIDS than the general population. In Tasmania 89% of pharmacists
believed that AIDS was a very serious or reasonably serious health risk for
.intravenous drug users in that state. Two thirds (65.8%) of rural Victorian
pharmacists saw the risk of spreading AIDS through injecting drug use as high to
very high and 79% saw the connection between needle sharing and the spread of
AIDS as very strong (Jennings, 1988). Figures from the Melbourne study also
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indicated 56% of phannacists thought there was a high risk of HN infection
s;m:ading extensively among injecting drug users from whom, phannacists
believed, the potential for further spread to the general population was moderate
to very higb (Monash Medieal School, 1987).

Phannacists' role in relation 1D AIDS.
In Victoria 82% of phannacists believed they had a special role ill relati•>n to the
control of AIDS (Jemtings, 1987; Monash Medieal School, 1988). The main role
they saw for themselves was the provision of advice and counselling. Dispensing
literature on AIDS and drug rehabilitation was seen as appropriate in many
country phannacies and 82.9% of phannacists were prepared to do so (Jemtings,
1987). The other most frequently nominated roles were the sale of needles and
syringes to injecting drug user.; and the sale of condoms.

Snmmwy.
It is apparent from these studies, which were all conducted soon after the

initiatives to provide needles and syringes were implemented, that pharmacists
were well infonned of the seriousness of HIV, especially to injecting drug users.
The majority of phannacists also believe that they have a special role to play in
relation to the control of AIDS.
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Needle St•wly Pmctices
An increasing number of pharmacists throughout Australia have taken up the
challenge to help prevent the spread of blood-home disease by adopting the harm
reduction strategy of supplying sterile injeeting equipment to injecting drug users.
This trend was first noted in New South Wales by Tsai, Gob, Webeck and
Mullins (1987) who found that there was a significant favourable shift in
pharmacists' attitudes towards selling needles and syringes to injecting drug users
in the four months between the public launch of the Anti-AIDS Kit in Decemoer
1986 and the survey conducted in March 1987, from 14.1% before to 57.6% after
the launch. While the survey results revealed that over half the pharmacists
supported the needle dis1ribution program only 11.9% actually sold Anti-AIDS
Kits at the time. The other 45. 7%, however, were willing to supply but had not
been approached. The majority of pharmacists in New South Wales now supply
sterile injecting equipment, and many are also involved in needle exchange. One
of the factors that probably influenced the early and rapid adoption of the sale of
needles and syringes in that state was that, in 1985, the New South Wales

Government amended legislation thereby removing the sanctions of seiiing or
possessing needles and syringes.

Figures from Victoria indicate that although needle and syringe supply started
well, it increased at a slower pace. For example an early study by Guastella and
Roller ( 1986) found that of 36 randomly selected Melbourne pharmacists 36%
had sold needles and syringes to injecting drug users and a further 11% intended
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to. In comparison, four years later in 1990 Mullins (1990) reported that 59% of
pharmacists were current sellers, representing only a 12% increase in that time,
although 14% of pharmacists in this study were past sellers. Mullins' study
however only had a 38o/ response rate so the representativeness of the sample
comes into question. In addition, it could he argued that another factor that may
effect the comparison between the two studies is that the first study was of
metropolitan pharmacists only, while Mullir.s surveyed all Victorian pharmacists.
However the fmdings of two other studies in 1987 would not support this
argument as the Monash Medical School's ( 1987) survey of metropolitan
pharmacists found that 45% were current sellers, compared to Jennings (1987)
fmdings that 63% of pharmacists in 10 country cities were current sellers and a
further 11% intended selling.

The Tasmanian experience differed again and pharmacists were much slower in
adopting the practice of selling needles and syringes to injecting drug users. The
results of Cuatt's (1989) study indicated that by 1989, only 32% were selling
steriie injecting equipment to the general public. At that time, however, it was still

an offence in Tasmania to possess a needle and syringe if it was to be used to
administer an illegal substance, a factor which affected 31% of the non-sellers
who responded that a change in the legislation would encourage them to supply.
In addition, the Tasmanian State government did not support the strategy to the

same extent as other state governments at that time.
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In Western Australia evidence shows that the number of phatmacists selling
needles and syringes has increased despite the fonner legal ssnctions. For
instance, in 1988 there were 72 outlets selling Fitpaclcs, which increased to 196
by 1990,44% of the total Western Australian pharmacists (Swensen, Westlund &
Baker, I 990 ). Of these, there were 169 metropolitan and 25 country phannacists,
a participation of 56% of metropolitan and 25% of country pbannacists. In 1994
Kerry (1994) reported

!ha~

based on infonnation from order forms, approximately

78% of pbannacists were selling Fitpacks, a 34% increase since the earlier study.
As these figures are only related to the sale of Fitpacks and don't include needles
and syringes sold in other fonns it is possible that an even higher percentage of
phannacists are involved in the provisim1 of needles and syringes to injecting
drug users in Western Australia This was the case in Greig's (1992) earlier
survey of pharmacists where 83% of pharmacists sold Fitpacks and a further 3%
sold only single needles and syringes to injecting drug users. It is interesting to
note that accvrding to Greig's study, 83% of pharmacists were selling Fitpacks in
1992 compared with the 78% quoted by Kerry in 1994. Considering the

proportion of current sellers in Western Australia it i!: apparent that the legislation
did not deter the majority of pharmacists from adopting the harm reduction
strategy of supplying needles and syringes to injecting drug users. It must be
remembered however, that the practice was officially condoned.
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Difficulties ExPerienced by Pbannacisls
The most common factor cited for not selling needles and syringes was concern
about injecting drug users frequenting the pharmacy (Tsai et al, 1988; Cuatt,
1989; Monash Medical School, 1987; Guastella & Roller; Greig, 1992). For
example in the early days of needle and syringe supply Guastella and Roller
(1986) found that for 55% of pharmacists who said they did not intend to sell

needles and syringes to injecting drug useiS the commonest reason given was that
they did not want to attract 'this type of person'. Some felt they would be
overcome by 'undesirable's. Tsai, Gob Webeck and Mullins (1987) also found that
the majority of pharmacists who said they would not sell Anti AIDs Kits were
wonied about the anti-social behaviour of injecting drug users. More recently, of
Western Australian pharmacists who had never sold 54% did not like the clients
and feared assault (Greig, 1992). More specific reasons given include increased
security risk and shoplifting (Tsai et al, 1988) and drug abusers being aggressive
and unpleasant - cited by 94% of nonsellers (Monash Medical School, 1987).
However, the Monash Medical School (1987) claimed that fear from the

behaviour of injecting drug users was, t.o a large extent, was not borne out by the
experience of the pharmacies that did sell. Other factors cited for not selling
included moral and ethical reasons, belief that it would increase drug addiction,

adverse effects on other customers, complaints from other customers and legal
uncertainty in one case already mentioned.
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An average of 7.9% of past sellers were identified in four surveys, ranging from
'

4.5% to 14% (Greig, 1992; Jennings, !987; Monash Medical School, 1987;

Mullins, 1990). Past sellers main reasons for no longer participating included fear
and/or experience of threat and/or assault (Jennings, 1987; Greig, 1992)
undesirable or disruptive customers (Jennings, 1987), the unsavoury nature of the
practice and harmful effects on the business (Monash Medical School, 1987).
There is little information about problems experienced by current sellers. MSJ
Keys Young, however reported that 25% of current sellers did not like the
customers that Fitpacks bring. In addition, the study conducted by the Monash
Medical School (1987), just before the legislative change to permit needle and
syringe supply, found that the main factor troubling current sellers was
uncertainty about the legal and ethical principles of the practice.

Summruy

From the studies reviewed the main difficulty for pharmacists, regardless of
supply practice, concerns having injecting drug users in their pharmacy and the

associated problems. However, the legal ramifications was a consideration in
some instances where it was still an offence to supply needles and syringes to
injecting drug users.

Review Summa:ry
This chapter has presented the background to the provision of needles and
syringes to injecting d.-ug users by pharmacists. It reveals why it is important that
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these initiatives be continued and identifies issues that may impact on supply
practice. The review of previous studies has additionally revealed attitudes,
practices and experiences of pharmacists regarding these issues.
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CHAPfER THREE

Method

Omanisatiooal Supporj

In conducting this research endeavour every effort was made to ensure its smooth
running, embracing ethical principles to legitimize the study and enbaoce the
cooperation of phannacists, ever mindful that a good response would add weight
and credibility to the findings. An important aspect of this approach was to elicit

the support of the phannacists' professional organisations.

In Western Australia two professional organisations with which pharmacists are
associated are The Pharmaceutical Council of Western Australia and The
Pharmacy Guild of Australia. The Pharmaceutical Council, which is the
administrative body of the Pharmaceutical Society of Australia in Western

Australia, is the organisation with which all community pharmacists are registered.
The Council also administers the phannacists' trainee programme and provides
continuing education for phannacists (Megan Williamson, personal
communication, September 14, 1994). The Pharmacy Guild, of which 95% of

Western Australian community phannacists are members, is an employee
organisation registered with the Federal Industrial Commission, and aims to
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"represent the interests of members in industrial matters and to further and protect
the interests of, and generally do anything which may be considered beneficial

for, its members" (Nick Geronimos, personal c'Jmraunication, September 14,
1994). Because of the involvement of these organisations both were approached
prior to the commencement of the study in order to inform them of the proposed

research and enlist their support

Consultation took place with both organisations during the development of the
pilot and final questionnaires. Both organisations endorsed the study and have

expressed their interest in receiving the final results. In addition a Survey
Certificate was issued by The Pharmacy Guild of Australia (see Appendix B) with
a number and rating to be conveyed to pharmacists as an indication of the Guil<fs
approval of the study. Approval of the pharmacists' professional bodies was
sought out of courtesy and for the sake of a smoothly executed study (Gay, 1987,

p. 102).

Researeb Design
A descriptive research design was employed "to answer questions concerning the
current status of the subjects of the study" (Gay, 1992, p. 251), utilising the selfreport mail survey method for the collection of data. According to lsaac and
Michael (1971) this is an appropriate method to determine what others are doing

in

si~ilar

situations, make comparisons. and benefit from their experience in

making future plans and decisions. As the study included pharmacists throughout
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Western Australia a mail survey was chosen because of its usefulness in gathering
data from persons in "widely scattered locations covering a large geographical
area" (Clover & Balsley, 1979, p. 95).

Sample of Subjec!s
Based upon information provided by The Pharmaceutical Council of Western
Australia there are 466 registered community pharmacies in Western Australia
From the list of these pharmacies provided by the Council a stratified random
sample (N

~

130) was selected on the basis of metropolitan and country location.

Metropolitan pharmacies were distinguished as those within the Perth local
telephone call range. Of the 130 subjects chosen 85 (65%) metropolitan and 45
(35%) rural pharmacists were targeted. This did not represent an equal proportion
of metropolitan and country pharmacists, which was 74% and 26% respectively.
There were two reasons for altering the ratio of pharmacists for the study. Firstly,
based on the true ratio, only 34 country pharmacists would be targeted and,

considering the average response rate was 48% in simiJar AustraJian studies
utilising self administered questionnaires (Mullins, 1990; Cuatt, 1991; MSJ Keyes
Young, 1991 ), a return of only 16 questionnaires could reasonably be expected.
With the further division into sellers and non-so:llers, bearing in mind Kerry's
(1994) claim that The Pharmacy Fitpack Program currently operated from 78% of
pharmacies across Western Australia, the numbers could be reduced to cells of
approximately 12 sellers and 4 non-sellers which would not give significant power
for the analysis. Secondly, previous formal studies regarding the issue of needle
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and syringe supply have not surveyed country phannacists in Western Australia,
and it was thought that by increasing the ratio of country pharmacists in this
research this deficiency could be redressed.

Using a standardised telephone inlerview format (see Appendix C) the phannacist
in whose name the pharmacy was registered was approached to complete the self

administered questionnaire. It was found in some cases however, that a manager
rao the pharmacy, so in these instances the manager was asked to participate. In

three cases a re-draw was made for the following reasons:
I. One pharmacy did not answer the telephone after being called three
times on each of four successive days. Two further calls on two days of the
following week also failed to elicit a response.
2. Two pharmacies drawn from nearby country towns were owned and run
by the same pharmacist who travelled between them, each pharmacy having his

services at certain times. Needles and syringes were not sold at either pharmacy
due to there being no demand. It was felt that it would serve no purpose to have
the phannacist complete two questionnaires.

3. One pharmacist was on holidays for four months and a locum was
running the pharmacy. As infonnation sought was related to the attitudes and
practices of the pharmacist who owned or managed the pharmacy and who was

involved in making policy decisions, a re~draw was made.
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Questionnaires
Two separate questionnaires, relevant to the current selling practice of
pharmacists, were specifically desigoed for the study (see Appendixes D and E).
The content of both questionnaires was the same except for the sections
concerning current selling practices. Adoption of this strategy minimised the need
for numerous speci.J instructions and decreased the length of the questionnaires.
This had the benefit of ease of self-completion by respondents with a view to
increasing the response rate.

Pilot of the Questionnaires
Initially the questionnaires were piloted by I 4 persons including nine health
professionals, two alcohol <:ounsellors, two general practitioners and three
phannacists. This represented 11 professionals who understand the study's purpose,
... potential 'users' of the data [and] people ... from the population to be surveyed",
a strategy suggested by Dillman (1978, pp. I56-!57). Persons other than
pharmacists were asked to adopt the role of seller, non-seller or past seller as
indicated on the top of the questionnaire so that an sections of the questionnaires
were tested. A brief statement (see Appendix F), outlinmg the study's purpose and
the procedure to be undertaken in conducting the survey was included, with a
request for comments on any difficulties or ambiguities found in the
questionnaire, suggestions for improvement and for the time it took to complete.
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All respondents agreed that the format of the questionnaires was appropriate,
unambiguous and the questions easy to complete. The average time for
completion was 17 minutes, ranging from seven minutes to 40 minutes. There
were seven suggestions for inclusion of extra question categories, each of which

was given careful consideration resulting in one fmally being adopted. This was
the inclusion of "vending machines" in Item 8 which asked where pharmacists

think nee.dles and syringes should be obtained. In addition, the suggestion that the
words "the prevention of' be included in Item 7 was also adopted to now read,
"What role do you think pbannaci'ts should play in relation to the prevention of
HIV and Hepatitis"?

Content of Questionnaires
The questionnaires were divided into a number of domains including public

health, needle and syringe distribution, current practices, legislation, attitudes to
injecting drug use and injecting drug users, and demographic details. Ordering of
the questions was based on suggestions by Dillman (1978). This included piacing
questions which respondents were most likely to see as socially important or

useful first and the least useful last; grouping questions of similar content
together, and within content areas, by type of question; and taking advantage of
cognitive ties that respondents were most likely to make among groups of
questions.
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Public health.
The first set of questions related to pharmacists' beliefs about public health in
relation to HIV, hepatitis C and injecting drug use. This section was included in
an effort to gauge phannacists' perception of the significance of these issues in
Western Australia and what they believe their role to be in relation to the
prevention of HIV and hepatitis C.

Needle and syringe distribution.
To detennine phannacists beliefs concerning needle and syringe distribution this
section included questions concerning where (e.g., hospitals, drug treatment
agencies, phannacies), and how (e.g., buy, exchange) injecting drug users should
obtain new equipment. Other questions related to phannacy policy regarding the
sale of needles and syringes to injecting drug users and whether phannacists

supported the govenunent's harm minimisation strategy concerning needle and
syringe supply. Also included in this domain was a question regarding training in
an attempt to ascertain to what extent pharmacists have had training regarding the
supply of injecting equipment to illicit drug users, and to identifY whether there

was a need in this area.

Current practices.

This domain focused on pharm;,tcists' practices in relation to the supply of needles
and syringes to injecting drug users in the pharmacy in which they were currently

located. As mentioned earlier, questions in this domain differed for pharmacists
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who do and do not sell needles and syringes. As this section included some
potentially sensitive items it was placed towards the centre of the questionnaire
with the more sensitive items embedded within other items (Dillman, 1978).

For the pharmacists who do supply needles and syringes to injecting drug users,
items included when they commenced supply; factors influencing the decision to
supply; in what form they were supplied (e.g. Fitpacks, single syringes, etc);
approximate quantity; and cost to the customer. This domain was also concerned
with problems experienced in the pharmacy concerning sale of needles and
syringes and the influence this had on selling practice.

For the non-sellers this domain included questions concerning supply of needles
and syringes to persons other than illicit drug users, whether needles and syringes
had been sold to injecting drog users in the past and future intentions regarding
supply of injecting equipment. Reasons for not supplying were determined and
problems experienced in the pharmacy concerning irtiecting drug users and the

influence on selling practices were identified. To conclude this domain both
questionnaires included a question concerning the dispensing of methadone to see
whether differences e>:ist between sellers and non-sellers.

l,.eJ:islation.

With the recent change in legislation enabling pharmacists and health care
workers to legally supply needles and syringes to irtiecting drug users this domain
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was included to detennine phannucists' knowledge of the current legal status of
supply, and its effect on selling practice. In addition, it aimed to indicate the
deterrent eftect of the legal status of needle and syringe supply before the cbange.

Attitudes to injectin: drug use and injecting drug

useJS.

In order to gauge phannacists' attitudes toward injecting drug users this domain
was included utilising questions from an instrument devised by Ross and Darke
(1992), the Attitudes Towards Injecting Drug Users Scale (AIDUS). For
convenience and to contain the Jength of the questionnaire, ten questions were
selected from the 50 item scale. The items were selected based firstly, on their
having obtained a correlation co-efficient in the moderate to strong range when
tested by Ross and Darke for test-retest reliability, and secondly, on their
perceived appropriateness. As previously discussed attitudes to drug users can
influence the outcome of treatment and by ascertaining pharmacists' attitudes
towards injecting drug use and injecting drug users it could give some clue as to
whether this affects supply practices.

Demoeraphic details.
Contrary to the current convention (Tony Fetherstonhaugh, personal
communication, April 6, I994), de;nographic details were placed at the end of the
questionnaire. As Dillman (I978) points out, it has often been believed that
placing this section at the beginning results in fewer nonresponses to these
crucially important items and that they act as icebreakers giving respondents time
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to settle. However Gay (1992), Babbie (1986) and Dillman (1978) agree !bat in a

mail questionnaire demographks should be placed at the eod because there is no
need for icebreakers as there is no interviewer present to generate nervousness. In
addition, according to Dillman (1978) experience shows that placing these
personal details at the end of a mail questionnaire does not lead to nonresponse,
and in his opinion this may be because respondents view the filling out of the
earlier pages of the questionnaire as an investment and unless they fiU out the
personal details the investment is lost

For the demographic section of the current study items included personal details
of pharmacists concerning year of graduation, length of time working in the
profession, time in the current pharmacy, age and gender. Details of the pharmacy
were also sought including staff numbers, location, opening hours, customer
groups and postcode.

To conclude the questionnaire pharmacists were invited to add further comments
on the issues in the questionnaire or suggested strategies that might be useful for
pharmacists in dealing with injecting drug users. Finally pharmacists were asked
to indicate whether they required a summary of the results.

Reliability aod Validity of the Questionnaires
The questionnaires were designed using questions and adaptations from previous
similar Australian studies (Cuatt, 1989; Jennings, 1987; The Monash Medical
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School, 1987; Tsai et al., 1988;) and some newly developed questions where
others were not av&lable to elicit the infonruttion required. The section
concerning attitudes to drug use and drug usero were selected from a
questionnaire designed 1111d tested by Ross and Darke (1992).
The internal consisteocy of the scale to measure attitudes to injecting drug use
and injecting drug users was tested on the results with Chronbach's coefficient
alpha of .68 indicating that the scale was moderately reliable. While no other
reliability and validity measures were undertaken, the questionnaire was piloted
and was examined and approved by the Phannaceutical Council of Western

Australia and The Pharmacy Guild of Australia.

Initial Telephone Contact
Using a standardised format (see Appendix C), as previously mentioned,
telephone calls were made to selected phannacists to infonn them of the study
and ask them to participate. The importance and value of their participation was
expressed and an assurance of confidentiality of infonnation was given. At this
timo they were also advised that the Pharmaceutical Council of Western Australia
and the Phannacy Guild of Australia approved of the study. In addition,
pharmacists' current practice concerning the supply of needles and syringes to
injecting drug users was determined. This had two purposes. Firstly, to establish
which questionnaire to forward to. those willing to participate, and secondly, to
ascertain the current supply practice of non-respondents. The calls were made
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over a period of four days in the first week of July, 1994. Details of each call
were entered onto a prepared form (see Appendix G) to record the outcome.

Mail Out
Once the pharmacists willing to participate were identified (n

~

129) and their

current supply practice determined, a package of material was posted to them.
This consisted of the relevant questionnaire, the cover letter (see Appendix H) and
a return addressed reply paid envelope. Each questionnaire was numbered for
identification purposes in order to implement follow-up procedures if required.

Cover leUerThe cover letter (see Appendix H) outlined the pUipOse and significance of the
study, the size of the sample and the method of sampling. The imponance of the
pharmacist's valuable input was emphasised with an assurance of confidentiality.
Instructions for completion and return of the questionnaire were included adding
that a summaty of the findings would be available on request. Teiophone numbers
were provided for further information if required and pharmacists were thanked
for their participation.

When preparing the mail out, the greeting, the return by date (which was
designated as approximately two weeks from the date of postage), and the
Pharmacy Guild of Australia's survey approval number and rating were

handwritten on the cover letter.
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Follow-up Telephone Calls
Using standard fonnats (see Appendixes I and J) two follow-up telephone calls

were made to

non~respondents,

the first approximately two weeks after the due

date and the second a further three weeks later. A total of 12 replacement

questionnaires were forwarded to subjects, six after each

follow~up.

Uttem of Appreciation
Letters of appreciation were sent to all respondents infonning them of the
overwhelming response to the study and thanking them for their participation.
Details of the expected availability of the results were given. There was a slight
difference in the wording of the letters dependent upon whether the phannacists
required a personal copy of the results (see Appendixes K and L).

Similar letters were also sent to the Director of the National Services Division of
the Phannacy Guild of Australia in Victoria, the President of the Pharmacy Guild

of Australia in Western Australia and the Registrar of the Phannaceutical Council
of Western Australia (see Appendixes M, N and 0). In these letters, after

informing them of the cooperation of phannacists in responding to the study, and
the excellent response rate, appreciation was expressed for the assistance given by
the organisation. The expected availability of the results was also provided.
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Response Rate
Response ID the Initial Telephone Call
Of the sample of 130 pharmacists telephoned 129 (99.2%) consented to receiving

a questionnaire. The one refusal was from a country pharmacist who was happy
to provide the information that he sells Fitpacks but added that he does not fill in
questionnaires. One pharmacist agreed to have a questionnaire although he
claimed he did not usually participate in surveys, and probably would not
complete and return it; it depended on the content. He also declined to divulge his

current selling practice except to say that it changed over time. dependent on the
Pharmaceutical Council's recommendation. On these grounds he was forwarded a
seUer's questionnaire. A number of other issues were raised by pharmacists and
these included: one pharmacist advised that he would return the questionnaire
providing the questions were not too sensitive; three pharmacists expressed
concern that the findings of the research may misrepresent pharmacists' views or
misconstrue their feelings about the issues; and the importance of the inclusion of
the approval number from the Pharmacy Guild was expressed by one pharmacist.

In the main, pharmacists reflected a positive attitude towards the study and a
willingness to comply.

Response to the Study
From the 129 questionnaires distributed a total of 117 were returned representing
a response rate of 90%. Of these 90 (69'/o) were returned within the first two
weeks, 15 (12%) after the first follow-up telephone call and 12 (9%) after the
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final follow-up call. Of the non-respondents (n

~

12) two claimed to have

returned the questionnaire but these were not received; there were three refusals at
follow-up from pharmacists who either found the questionnaire too complicated
(!! = I) or too

sensitive(!!~

2); and while the other seven agreed to return the

questionnaire at the initial telephone call and also agreed at each of the two
follow-up calls, they failed to respond. Of the 117 questionnaires returned, 75
were from metropolitan and 42 were from country pharmacists. Of these 115 were
included in the analysis, one being discarded due to non-completion and one

arriving too late for inclusion. The usable questionnaires represented 88.46% of
the sample of 130 pharmacists approached to participate in the study. For a
detailed depiction of the response and follow-up see Appendix P.

According to Babbie (1986) a mail survey response rate of 60% is good, with
70% considered very good. However Dillman (1978) claims that with his Total

Design Method, for homogenous groups response rates can be expected to exceed
85% for mail surveys. The response rate in the present study is considered
particularly good, especially when compared to similar Australian mail surveys.
For instance, this included response rates of 37.8% for Mullin's (1990) study of
all Victorian community pharmacists, 48% for Cuatt's (1989) survey of all
Tasmanian Pharmacy Guild members and 58% for a purposive sample of New
South Wales pharmacists (MSJ Keys Young, 1991).
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Edrical Con_sidemtions
An important ethical consideration of the study was that phannacists be assured
that the infonnation they provide be confidential. As Ibis study in many ways

addresses sensitive issues it was important for the pharmacists that their responses
remain anonymous. This has been addressed by not requiring names on the
questionnaires, which have been identified only by numbers for follow-up
purposes. The cover letter explained this procedure to participants and they were
assured of confidentiality both in the cover letter and the initial telephone calL

In respect to informed consent the strategy of telephoning the sample of
phannacists before forwarding the questionnaires gave them the opportunity to

refuse to participate from the outset. Coercion was not used at any stage and for
the few phannacists who had concerns about the study it was explained that their
participation was completely voluntary.

The other dimension of informed consent gained for the study was that of the
pharmacists' "gatekeepers" (Homan, 1991, p. 82), the Pharmaceutical Council of
Western Australia and the Pharmacy Guild of Australia. One possible explanation
for the high response rate was the fact that approval of both organisations had
been given for the study. This may have added to the legitimacy and credibility of

the research and hence the response rate.
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Dam Analysis
Although most of the data were precoded, the data from open questions was
coded later, after which all data were entered into a Microsoft Excel 4 (1992)
spreadsheet which was then converted onto SPSS for Windows 6 (1993)
Statistical Package for the Social Sciences for the analysis.

During the analysis the pharmacies were divided into two groups in respect to
opening hours (those who opened for nine hours or less per day and those open

for more than nine hours) in order to detennine those with extended trading
hours. They were also grouped in respect to days, so that the nurober of days
open for weekdays and weekend days could be ascertained. These measures were

taken to detennine whether there were any differences betw-een selling practice in
terms of trading hours. In addition the positive questions in the Likert scale
regarding pharmacists' attitudes to injecting drug use and injecting drug users

were reverse coded so that the point vaJues of the negative and positive responses
were correctly calculated. As previously mentioned Chronbach's alpha was also

calculated on the results of this scale to test for internal consistency.

Frequencies and summary statistics; to discover the mean, standard deviation and
the range of scores, were caJcu1ated. These were used to describe the
characteristics of the sample, determine the extent to which pharmacists currentJy
sell needles and syringes to injecting drug users and determine the factors that
have influenced changes in supply practices over time.
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Additionally, calculation was conducted to determine the lilctors that differentiated
between current sellers and nonsellers. It was found that on the dependent variable
the groups were of a very uneven size and in some categories there were a very

small number of responses. This made the use oft tests inappropriate. Moreover,
some of the chi square analyses were unable to be conducted bc<:ause of
insufficient cell size. Therefore, as there were a large number of variables likely
to influence supply practice, to discover the relationships between the variables
interval variables were left as they were, nominal variables such as practice and
gender were dummy coded as 0 and l (Hills, 1994) and the independeT!I variables
were correlated with the dependent variable. Pearson's r was calculated, an alpha
level of .05 was set and degrees of freedom were set at 1!3.
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CHAPTER FOUR

Resul15

Sample Cbamcteristics
From the total of 115 useable questionnaires received the pao1icipants in the study
consisted of 94 males and 21 females. The age range of participants was from 21
to 64 with an average age of 42.36 (SD = I 0.56). Sixty four percent of

pharmacists were from the metropolitan region and 36o/o were from the country.
There was a 43 year span between the time participants registered as pharmacists
ranging from 1951 to 1994. The average time registered was 20.42 years (SD =
10.57). All participants had been working as pharmacists since registration with
the years of experience as a pharmacist ranging from I to 43 years (M = 20.42,
SD = 10.57). The length of time pharmacists had worked in the present pharmacy
ranged from 3\1, months to 35 years, an average of 8.41 years (SD = 7.78).

The most common location of pharmacies was in strip type shopping (37"/o),
followed by neighbourhood shops (30%), regional shopping centres (14%),
medical centres (9%), Central Business District (5%) and isolated locations (4%).
The number of equivalent full time staff employed at pharmacies ranged from
none to 16 with a mean of 3.4 (SD = 2.99). From a range of options, of which
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more than one could be selected, respondents were asked to indicate the largest
customer groups in their pharmacy. The results revealed that elderly people were
among the largest group of customers for 68% of pharmacists, young families
followed for 57%, unemployed - 49%, professional/office workers - 20%, passing

trade- 19%. students - 7% and "alternatives" for 4%. Other customer groups
mentioned, each by 3% of pharmacists, were fanners, miners and rural workers.

Details of the opening hours and the percentage of pharmacies open on specific
days and times are presented in Table 2. Monday, Tuesday, Wednesday and
Friday hours which were very similar have been averaged and presented together.
Thursday, Saturday and Sunday hours are presented independently. There was a
wide range of opening hours of pharmacies with more than half (55%) opening

Table 2

Pharmacy openine: hours
% Phannacies

Days
Mon, Tue, Wed & Fri'
Thursday
Saturday
Sunday

<=9
hours

45
28
76
ll

Hours open

>9
hours Not open

55
72
22
17

0
0
2
72

Range

3.5 -16
3.5- 16
3- 16
2- 16

9.87
10.59
7.16
9.98

1.76
2.12
3.47
3.72

Note. Six cases missing, (g = 109) .

•Mean percentage over the four days.
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more than nine hours during the weeli except Thursdays with 72%. Only 2% of
pharmacists did not open at all on Saturday with 22% opening extended hours. A
total of 28% opened on Sunday with 17% opening for extended hours. The range
of hours open differs between weekdays and each weekend day with the widest
range being 2 to 16 how·s on Sundays. Six pbarmacists were not included in this
analysis because they either did not respond to the question or gave invalid

answers.

The Extent tu Which Pharmacists Currently Supply Needles and Syringes
to Injecting Drug User.1

The study revealed that of the 115 pharmacists who participated in the study 88%
(!l ~ 101) currently sell needles and syringes to injecting drug users. The same

proportion of sellers was achieved at the initial telephone contact when the total
sample of pharmacists (N

~

130) were asked whether they currently sold needles

and syringes to injecting drug users, indicating that there was no difference
between respondents and nonrespondents in regard to selling practice. Of the 12%
(!l ~ 14) of nonselling pharmacists 9 were past sellers who had previously sold

needles and syringes to injecting drug users but had reversed their decision to sell,
and 5 had never sold. As there was a small proportion ofbotl1 past sellers (8%)
and pharmacists who had never sold (4%) both were combined into the nonsellers'
category for the analysis except where specified.

A breakdown of the figures revealed that 86% (!l ~ 64) of pharmacists from the
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metropolitan region and 90% (!! = 37) of pharmacists from the country were
current sellers. Nonsellers included 10 metropolitan (71%) and 4 country (29%)
phannacists. :rable 3 shows. the supply practice· of participants ·by·lecation with
metropolitan and country current sellers making up 56% and 32% respectively of
the total participants in the study.

Table3
Suoll:: J!raetice of J!BrticiJ!ants bl: location
Participants
Metro

Country

Total

n(%)

!!(%)

n(%)

Current Sellers
Nonsellers

64(56)
10(9)

37(32)
4(3)

101(88)
14(12)

Total

74(64)

41(36)

115(100)

Supply Practice

lnjecfing Equipment Sold
Pharmacists sell sterile injecting equipment in a number of forms and various
quantities. Ninety seven percent (!! = 98) of current sellers sell Fitpacks, with the
number sold ranging from 0 to I 00 per week with an average of 17.24 (SD

=

50.62). Single needles and syringes are sold by 22 pharmaci.sts (22%) ranging
from 0 to 200 per week with a mean of 38.89 (SD = 50.62). Three current sellers
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(3%) indicated that they sell needles and syringes to injecting drug users in insulin
packs of 10. Fitpacks are sold at prices ranging between $3.00 and $5.95 with an
average price of $4.05 each (SO =58 cents). Single needles ranged in price from
20 cents to $1.00 eaeh (M= 57 cents, SO= 23 cents) with insulin packs between
$3.95 and $5.00.

Phanru!cy Policy

Overall 77% of pharmacists (n = 88) indicated that they had a policy concerning
the supply of needles and syringes to injecting drug users. This included 75% of
current sellers (n

= 76) and 86% ofnonsellers (n = 12). The main points of the

policies were coded into categories and are summarised in Table 4. Some

Table 4
Main points of pharmacy policy regarding the

sale ofN&S to ID Us

Main points
Sell only Fitpacks
Sell on request
Don't sell N&S to ID Us
Sell without judgement

Phannacist's authorisation required
Sell Fitpacks and singles
Other

n(%)

50(43)
18(16)
12(10)
7(6)
6(5)
3(3)
16(14)

Note. N&S needles and syringes. IDUs =injecting
drug users.
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pharmacists listed a number of points to their policies. The most common policy
was to 'sell Fitpacks only', followed by 'sell on request'. The nonsellers all had
only the one policy of not selling to injecting drug users.

Factors That Have Influenced Changes in Supply Pmctice Over Time
Current SelleB

Before reporting the factors influencing changes in supply practice, it is
important to note when pharmacists started to supply needl<:s and syringes to
injecting drug users. Of the I 0 I pharmacists who sell needles and syringes to
injecting drug users 8% (!!

~

8) did not indicate when they began to supply and a

further 8% did not know or were unsure. As there were 16 missing cases
percentages were based on the 85 pharmacists who did specifY when supply
began in their pharmacies.

The results showed that phannacists began supplying needles and syringes to
injecting drug users in 1980 (before the advent of AIDS) when 2 pharmacists
adopted the practice (see Table 5). However, taking up the practice was sporadic

in the early 1980s. By July 1987, when government initiatives concerning the
supply of sterile injecting equipment as a preventive measure in the spread of HIV

were implemented, a further 6 pharmacists were selling to injecting drug users.
One pharmacist who began supplying in 1987 did not stipulate the month started

so it is not known whether he or she began supplying before or after the
government initiatives were implemented. Since 1987 the number of ~uppliers has
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TableS

Year pharmacists began supply
ofN&S to IDUs
Year

n(%)

1980
1984
1985
1987
1988
1989
1990
1991
1992
1993
1994 •

2(2)
2(2)
3(4)
5(6)
9(11)
11(13)
16(19)
9(11)
16(19)
9(11)
3(4)

Total

85(102)b

Note. Only 85 valid answers

received for this variable.
'To July 1994. bPercentages do not
add to 100 due to rounding.

been steadily increasing with an average of 12 pharmacies adopting the practice
each year from 1988 to 1993, with a range of 9 to 16 per year. The most recent
time a pharmacist began supplying needles and syringes to injecting drug users
was April1994. The 1994 figures are to July of that year when the survey was
conducted.
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Factors influencing the change.
When asked to rate the degree of importance of a number of factors in

detennitting th.eir decision tfl start selling needles and syringes, the vast majority
of current sellers (92%) rated as important or very important that they became

more convinced that the supply of injecting equipment was essential to the
reduction of transmission of disease (see Figure I). The belief that disruption was
unlikely to occur in their pharmacy was important or very important to almost
half (48%) of selling pharmacists. In regards to the law, 40% of current sellers'
decision to supply was influenced by the fact that no prosecutions had been laid
for selling needles and syringes to injecting drug users and 25% rated the
impending legislative change as important or very important. Only 9% saw it as

an important commercial decision. A number of other reasons were given, the
most frequent (!! - 5) being response to the Health Department of Western

Australia's initiatives and/or the Pharmaceutical Council's recommendations. Other
reasons reported by a small number of individual pharmacists included: refusal to
supply attracted abuse, L'ueats and general intimidation; the possible reduction of
burglaries; the hope that used syringes would be properly disposed of; as a

community service; and because customers asked for them. For one phannacist
the decision was influenced by more personal considerations for he/she stated that
"if the person carrying HIV transmitted it to my child and it could have been

prevented I r.ould not 'forgive myself so this was a semi-personal decision".
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Figure 1. Factors influencing current sellers' decision to sell needles and syringes
to injecting drug users_
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Future intentions.
Of the 101 current sellers 93% (!l ~ 94) intend to continue selling needles and
syringes to injecting drug users, 2% (!l ~ 2) indicated they did not intend to

continue selling, 2% were ambivalent about continuing the practice ~. 11d 3%
(!l

~

3) failed to indicate their future intentions. One metropolitan pharmacists

explanation for discontinuing sales was that he was waiting until the new
legislation was sorted out as the Pharmacy Guild was still figuring out what could
be sold by pharmacists without paperwork hassles. The other current seller's

reason for ceasing sales, a country pharmacist, was because of the requirement for
data collection and the time required, together with no training being provided.
For one pharmacist ambivalent about his future selling practice, the indiscriminate
disposal of needles and syringes and the drug users' apparent lack of respect for

themselves and the community caused conc-::m. However, at various times he felt
that, as a community pharmacist, he was the best equipped person to handle the
distribution of needles and syringes. The other ambivalent pharmacist felt there
was possibly enough outlets for users to purchase syringes.

Past selleB

As reported earlier 9 (64%) of the 14 nonsellers had previously sold needles and
syringes to injecting drug users but had discontinued the practice. Of these past
sellem three stopped supplying needles and syringes to injecting drug users in
1990, 3 stopped in 1993 and 2 stopped selling in 1994. One pharmacist failed to
indicate when he/she stopped selling.
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Factors influencine the discontinuatioD of supply.
Important factors in phannacists' (!! ~ 9) decision to stop selling needles and

syringes to injecting drug users are shown in Figure 2. The factors most often
reported as important or very important in their decision to stop supply was
disruption in their pharmacy by 89% (!! ~ 8) of past sellers followed by incidents
that threatened the safety of staff and/or other customers by 78% (!! ~ 7) and
ethical concerns about the practice by 55% (!!

~

5). Less than half reported

shoplifting, community attitudes to the practice and the legal ramifications as

factors in their decision to stop selling. Other factors important to the decision of
past sellers to stop supply included: the incidence of indiscriminate disposal of
needles and syringes, reported by 2 phanmar,ists; concern about possible

cancellation of shop insurance due to the number of break-ins experienced, as
well as the disruption to the phannacisfs home life as a result of ca11-outs in one
case; and the belief by one phannacist that supplying needles and syringes would

not reduce the spread of HIV because two or three "users" would come into the
phannacy at a time and buy a single needle/syringe.

Future intentions.
Thirteen nonsellers (93%) indicated that they did not intend selling needles and
syringes to injecting drug users in the future. Nine pharmacists (64%) said that

nothing would encourage them to seii injecting equipment to injecting drug users.
However, three (14%) reported that if there was evidence that drug users were
receiving counselling or rehabilitation to change their drug use they would sell to
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Figure 2. Factors influencing past sellers' decision to stop selling needles and
syringes to injecting drug users.
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them, one phannacist would sell if he "thought there was a way of cutting down
on the problem" and one pharmacist said he would sell if drug users appeared. It

is interesting that disruption and threats were a major reason for discontinuing
sales but guarantees of safety did not feature here.

Facto m 1hat Differentiate Between Current Sellem and Nousellem of Needles and
Syringes ID Injecting Drug Users

To detennine the factors that differentiate between sellers and non-sellers of
needles and syringes to injecting drug users variables likely to impact on practice
were correlated with current practice (see Table 6). The results reveal a
relationship between a number of variables and current selling practice indicating

possible factors that influence phannacists' decision about supplying sterile
injecting equipment. These factors are as follows:
I. Current sellers are slightly more likely than nonsellers to regard the
HIV virus as a serious health risk to injecting drug users,! (113)

~

.19, 11 < .05.

2. Current sellers are more likely to think the use of non-sterile injecting
equipment is a hazard to injecting drug users, ! ( 113) = .30, 11 < .0 I.
3. In relation to the role pharmacists should play concerning HIV and

hepatitis current sellers are more likely to think pharmacies should sell needles
and syringes to injecting drug users,! (113) = .67, 11 < .01.
4. Current sellers are more likely to think that injecting drug users should
obtain needles and syringes from pharmacies,

r (113) ~

.65, 11 < .01.
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Table6
Correlation between selling practice and oossible influencine: factors

r

Factors
Seriousness ofHIV to the general public
Seriousness ofHIV to IDUs
Seriousness of hepatitis C to the general public
Seriousness of hepatitis C to IDUs
Significance of hazard of injecting drug use to the general public
Significance of hazard of injecting use to IDUs
Pharmacists should sell needles and syringes
IDUs should obtain needles and syringes from pharmacies
IDUs should pay for needles and syringes
Support of WA Health Departments strategy
Disruptive incidents in phannacy
Dispense methadone
Current legal status of needle anu syringe supply
Attitude to injecting drug use and IDUs
Year of registration
Experience as phannacist
Time in present phannacy

Age
Gender
Number of staff
Location of pharmacy
Mean hours open weekdays
Mean hours open weekends
Unemployed customers
Student customers
Elderly customers
Young families as customer group
Region

.08

.19*
.04
.16
.05

.30**
.67**
.65**
.26**
.05

-.37**
.05

-.12
.02
-.07
.08
.09

.ll
-.09

.12
.06
.07
.09
.20*
.09
-.06
.09
.05

Note. IDUs ~Injecting drug users.
*p < .05. **p < .Ol.
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5. Current sellers are more likely to think that injecting drug users should
pay for needles and syringes, r ( 113)

~

.26,Jl < .0 I.

6. Nonsellers are more likely to report disruptive incidents in their
pharmacy concerning injecting drug users, r (113) ~ -.37, I!< .01.
7. Current sellers are more likely to indicate unemployed as a large
customer group, r (113)

~

.20, ll < .05.

Other variables tested revealed no significant relationship to supply practice.

While these results reveal the significant factors differentiating between current
sellers and nonsellers, a more detailed description of the findings of particular

interest are presented in the following section.

Health Risk of RIV and HeJlatitis C

Overall 99% of phannacists view HIV as a serious or very serious health risk to
injecting drug users and 81% think it is a serious or very serious risk to the
general public. In comparison hepatitis C is viewed as serious or very serious to
injecting drug users by slightly fewer pharmacists with 93%, though more
strikingly, only 68% view hepatitis C as a serious or very serious health risk for
the general public. Figures 3 and 4 show the degree of seriousness with which

current sellers and nonsellers view these blood-borne viruses. As would be
expecte<> the data indicates that both current sellers and nonsellers believe that

these viruses are both more serious for injecting drug users than for the generaJ
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Figure 3. Current sellers view of the seriousness of HIV and hepatitis C to the
general public and to injecting drug users.
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Figure 4. Nonsellers' view of the seriousness of HIV and hepatitis C to the
general public and to injecting drug users.
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public. The only significant difference between current sellers and nonsellers
among variables in this group was that current sellers were slightly more likely

to regard HIV as a serious risk to injecting drug users. as previously shown.

Health Hazanl of Non-sterile InMng Equipment
Almost all pharmacists (98%) consider the use of non-sterile injecting equipment
as a significant or very significant health hazard to injecting drug users and 73%
consider it a significant or very significant health hazard to the general public. In
Figures 5 and 6 the degree of significance current sellers and nonsellers place on

the use of non-sterile injecting equipment to these groups is shown. For injecting
drug users 99% of current sellers and 85% of nonsellers viewed the use of nonsterile injecting equipment as a significant or very significant health hazard. This

finding was significant and indicated that current sellers were somewhat more
likely to think injecting drug users were at risk with the use of non-sterile

injecting equipment.

Training
Only six pharmacists (5%), all of whom were current sellers, reported receiving
any training regarding the sale of needles and syringes to injecting drug users. Of
these, two indicated they received training tluough the Pharmaceutical Council,
two by the Western Australian Alcohcl and Drug Authority and one by the
Health Department of Western Australia. One pharmacist had twice received
training, frrstly at Boots Pharmacies in London in 1976 and more recently in
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Figure 5. Current sellers' view of how significant a health hazard the use of non~
sterile injecting equipment is to the general public and to injecting drug users.
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Western Australia, although the body conducting the later training was not
specified. Five pharmacists had training in 1990 and one in 1992. No statistical

analysis was conducted concerning training due to the sma11 number of cases.

Support of lhe Health Depat1ment of Western Australia's Hmm
Minimisafioo Stra!Egy
Of the I J:l pharmacists who responded to this question 82% (!! ~ 92), comprising
89% (!!

~

90) of current sellers and 14% (n

~

2) of nonsellers indicated that they

support the Health Department of Western Australias strategy to sell needles and

syringes to injecting drug users for harm minimisation reasons. Ten percent
(!!

~

10) of current sellers do not support the strategy, yet still supply needles and

syringes. Conversely, 14% (!!

~

2) of nonsellers do support the strategy. There is

some difficulty in interpreting this data. While these figures may accurately

represent phannacists' stance on this issue it is possible that the use of the word

'support' in the question may have resulted in some ambiguity among phannacists.
It could be that some pharmacists interpreted support as meaning selling. They
may also not agree with the strategy ao a whole, but support the supply of
injecting equipment by pharmacists. For this reason, if the study were to be

repeated, the question could be reworded to ensure a clear understanding.

Disruptive Incidents
A total of 37 pharmacists (32%) overall have experienced disruptive incidents

concerning injecting drug users in their pharmacies. This included the majority of
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nonsellers (71%,!!
27"/o (!!

~

~

10) with a further two not responding to this question, and

27) of current sellers. As previously noted this was a significant

difference between current sellers and nonsellers.

The types of incidents experieneed by pharmacists were coded into four
categories with the results presented in Table 7. Of the 37 pharmacists who

experienced disruptive incidents 81% specified the nature of these incidents.
Some pharmacists have experieneed multiple disruptive incidents but each type of

incident is accounted for only once for each respondent. Where a phannacist
experienced more than one type of incident they were counted in each appropriate
category.

Table 7

Disruptive incidents experien~ed by pharmacists
Current Sellers Nonsellers
(!! ~ 101)
(~ ~ 14)
Type of Incident

Aggression/Abuse
Theft

Demands for attention
Disoriented/intoxicated customers

n(o/o)

n(%)

17(17)
2(2)
1(1)
5(5)

6(43)
4(29)
2(14)
1(7)
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The most common problem experienced was aggression and/or abuse to the
pharmacist and/or staff which was experienced by 43% of nonsellers and 17% of

current sellers. Aggression and abuse ranged from complaints to rudeness,
swearing, arguments, threats and violent behaviour, and was usually in regard to
either the cost of Fitpacks, temporary unavailability of Fitpacks, refusal to sell
single needles and syringes, refusal to sell other drugs, or the pharmacy's policy
not to supply injecting equipment to injecting drug users. In four cases the abuse

was associated with the dmg affected condition of the customer and their
impatience and demands for immediate attention.

The second most common incident was theft which was experienced by 4
nonsellers (29%) and 2 sellers (2%). Four of these cases were shoplifting, one
nonselling pharmacist had experienced various hold-ups and robberies and another
had his pharmacy broken into three times and each time the only things stolen

were syringes and Fitpacks. Other incidents arose from demands for immediate
attention in 3 cases. and disoriented or intoxicated customers in 6 cases. Two
phannacists expressed concern about the effects of disoriented or intoxicated drug
users on other .customers.

'

Further statistical analysis to determine whether aggression/abuse was the major
difference between current sellers and nonsellers was not conducted as expected
frequency of at least 5 in each cell is required to do a chi-square test so cell sizes

were too small.
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Handline:; of disruptive incidents.
Of ti1e 37 pharmacists who experienced disruptive incidents 83% (l! ~ 31)
indicated how they handled the incidents, the results of which were coded into

four categories and are summarised in TabJe 8. Verbal conciliation was the most
often used strategy and was adopted by 30% of this group of pharmacists
including 36% of current sellers and 15% ofnonsellers. A further 19% asked or

told the customer to leave or go elsewhere. Of the pharmacists in the "other"
category 2 current sellers and I nonseller ignored the incidents, 2 current sellers
called the police, I current seller claimed they did not handle t.he incident well,

Table f

StratciPes used by pharmacists experiencing disruptive
incidents
Nonsellers

Total

(!) ~ 13)

(n ~ 37)

n(%)

!1(%)

'!(%)

9(36)
6(24)
2(8)
6(24)

2(15)
1(8)
3(23)
2(16)

11(30)
7(19)
5(13)
8(22)

23(85)

8(80)

31(84)

Current Sellers
(n ~ 25)
Strategy

Verbal conciliation
Asked person to leave
Served quickly
Other
Total

Note. Six pharmacists did not indicate how they handled

disruptive incidents.
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one current seller physically fought the drug users off and one said he/she
handled incidents with a great deal of problem and claimed there is no support for
pharmacists.

Olher Problems
Current sellers were also asked whether they had experienced any or any other
problems in their phannacy as a result of selling needles and syringes to iqjecting
drug users. Sixteen percent(!!= 16) reported other problems. Of these, 8
reported theft which included shoplifting in six cases, one break-in and a number
of burglaries experienced by one phannacist Requests for single needles resulted
in problems for four phannacists who had a 'Fitpack only' policy with two of the
pharmacists reporting abuse. Other problems experienced by individual
phannacists included: unhappy parents who discovered children using syringes
they had purchased at the pharmacisrs store; 'undesirables' tending to be offputting to other customers and lowering the image of the phannacy; regular
customers being 'appalled' to see needles and syringes being sold to injecting drug
users~

injecting drug users trying to gain credit or unauthorised prescriptions; and

one country pharmacist reported police enquiries (anonymous, no names
requested) of usage, sales times and amounts.

Many of the problems experienced by phannacists were of the same type as those

reported as disruptive incidents previously, indicating a difference in the way
phannacists categorised the incident or problem. This means that the comparison
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between current sellers and nonsellers regarding disruptive incidents is possibly
not correct due to the different perception of the incident If the study were to be
repeated some modification of the questionnaire would be needed in this area to

avoid this confusion.

Current J..ew!l Sllllus of Needle and Syringe Supply to Injecting Drne UseJS
When asked the current legal status regarding the sale of needles and syringes to
injecting drug users 60% (!! = 69) of pharmacists indicated that the practice was
legal, 17% (!! = 20) of whom qualified this by adding that approval was required
(see Table 9). Six percent l!! = 7) of pharmacists, all current sellers, reported that
the practice was illegal. One third of pharmacists either did not know or were
unsure of the current legal status, gave invalid answers or failed to respond to the
question. One possible explantion for this mixed response could be that the new
legal status was causmg some uncertainty for pharmacists.

To conduct the correlation analysis between sellers and nonsellers this variable
was re-coded into three groups including legal (consisting of the. legal and legal
with approval categories), illegal and missing (consisting of the don't
know/unsure, invalid and missing categories). As reported previously there was
no significant difference between current sellers and nonsellers on these results.

Influence of the current legal sfntus.

When asked how the current legal status infloenced their practice regarding the
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Table 9

Pharmacists' view of the current legal status of needle and
syringe supply to IDUs
Current Sellers Nonsellers

Total

n(%)

n(%)

n(%)

Invalid
Missing

45(45)
16(16)
7(7)
12(12)
4(4)
17(17)

4(29)
4(29)
0(0)
2(14)
0(0)
4(29)

49(43)
20(17)
7(0)
14(12)
4(3)
21(18)

Total

101(100)

14(101).

115(99).

Legal status

Legal
Legal with approval
Illegal

Don't know/unsure

Note. IDUs = injecting drug users.
'Percentages do not add to I 00 due to rounding.

sale of needles and syringes to injecting drug users of the 63% (n = 72) of
pharmacists who gave valid answers 84% (!1 ·'53) of current sellers and 100%

(!! = 9) of nonsellers indicated it did not influence their practice. Other answers

received were dependent on the response to the previous question.

AUirudes ro injecting drug use and injeding drug users

As outlined in Chapter 3 the positive statements on the scale measuring

pharmacists' attitudes to injecting drug use and injecting drug users were re-coded
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and the internal consistency of the scale was tested with a coefficient alpha of .68
indicating that the scale is moderately reliable.

Pharmacists average scores on the I 0 questions of the scale ranged from 1.3 to
4.2 with a mean of 2.74 (SD =.51). These figures reveal that on average
pharmacists are slightly negative in their attitude to injecting drug use and
injecting drug users. As already shown, there was no difference between current
sellers and nonsellers for this variable indicating that supply practice was not
influenced by pharmacists attitudes to injecting drug use and injecting drug users
as measured by this scale.

Nonselle111' Cunent Reasons for not Selling
Figure 7 depicts tl1e degree of importance nonsellers place on a number of factors
in determining their current decision for not selling needles and syringes to
injecting drug users. The factor rated by almost all nonsellers (93%) as
important or very important was concern about possible aggression towards staff
of the pharmacy. Almost three quarters (71%) did not want the type of people
who use drugs coming in1:o their pharmacy. For 21% the current legislation and
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Figure 7. Factors influencing nonsellers' current decision not to sell needles and
syringes to injecting drug users.
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possible prosecution was of concern indicating that these phannacists were
probably unaware of the change in legislation.

Other Issues
Almost a third of pharmacists (31%) added comments expressing a wide range of

opinions concerning the issue of the provision of need.Jes and syringes to injecting
dmg users. The only issue mentioned by more than 3% of phannacists regarded
counselling or trea1ment for injecting dmg users which 9% (!! = I 0) of
pharmacists alluded to.
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Discussion

The Extent of Current Needle and Syringe Supply
The findings of this study indicate that the vast majority of phannacists in
Western Australia have adopted the practice of selling needles and syringes to
injecting drug users. The finding that 88% of Western Australian pharmacists are
currently supplying sterile injecting equipment exceeds the former approximation
of 78% (Keny,I994) of pharmacists who sell Fitracks. As only 3% of suppliers
do not supply Fitpacks, this is not enough to account for the difference. This
difference may be due to sampling bias or, as Kerry's figures were obtained from
order forms for Fitpacks it could be that some pharmacists sold very few Fitpacks,

did not often re-order and were thus incorrectly counted as nonsuppliers. This was
the experience of Greig (1992) who found that many pharmacists contacted who
were thought to be nonparticipants in !he Fitpack program because they were not
on the re-order lists, had every intention of participating but were not yet ready to
re-order. The proportion of sellers in the current study is closer to the 86%
achieved in the telephone survey conducted by Greig in 1992. Greig's sampling

procedure, however, differed in that a non-randomised selection process was

adopted in an unsuccessful attempt to obtain a discrete nwnber of current sellers,
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nonsellers and past sellers.

An unexpected result in the current study is that a higher proportion of country
pharmacists (90%) supply needles and syringes to injecting drug users than do
metropolitan pharmacists (86%), although this difference was not statistically
significant. However, the proportion of country pharmacists currently supplying
represents a vast increase since 1990 when Swensen, Westlund and Baker (1990)
found that according to re-order forms, 25% were providing needles and syringes
through the SS5 Pack prognun. At that time 56% of metropolitan pharmacists,
more than double the proportion of those from the country, were involved in the
supply of SS5 Packs. These figures may indicate that pharmacists throughout the
state have responded to the call to help prevent serious blood-borne diseases and

are playing an important role in the government's harm minimisation strategy
although the points noted above should caution this interpretation.

Although increasing numbers of pharmacists have adopted the practice of selling
needles and syringes to injecting drug users 8% were past sellers who had
reversed their decision to sell. This is a higher proportion than the 3% of past
sellers (when taking into account that two respondents still sold single needles) in
Greig's (1992) evaluation of the Fitpack program. However, the figure compares
more favourably with Mullin's (1990) Victorian study where 14% of respondents
were past sellers and 59"/o current sellers, although only a 37.8% response rate
was achieved by Mullins so there was less

cha.~ce

of the findings being
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representative of the total population. In earlier Victorian studies 5% (Jennings,
1987) and 8.5% (Monash Medical School, 1987) of participants were past sellers
and these too had a smaller proportion of current sellers (63% and 45%
respectively) in comparison to Western Australia with 88%. These figures indicate
that less pharmacists cease supply in Western Australia

Facto" Influencing C!Jan&es to Supply Pmctice.
The most compelling factor that

encourag~.d

pharmacists to seU needles and

syringes to injecting drug users was their belief that the supply of sterile injecting

equipment was essential for the reduction of the transmission of disease. It is clear
that the implications of the use of non-sterile injecting equipment by persons
injecting illicit drugs is regarded seriously by pharmacists. While only five
participants specifically mentioned that their decision to seil was influenced by the
Health Department of Western Australia's and/or the Pharmaceutical Council's

recommendations, it is clear that the encouragement from these bodies and
education about the seriousness of the problem has influenced the participation in
needle and syringe sales in Western Australia.

These findings were similar to the experience of other states. For example, Tsai,
Gob Webeck and Mullins (!987) reported a significant favourable shift in
phannacists' attitudes towards selling in New South Wales after the public launch
of the Anti-AIDs Kit in 1986. ln Victoria the Monash Medical School (1987)
reported that many of the current sellers commented that they had adopted the
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practice in respci1se to the policy guidelines of the Pharmaceutical Society.
Moreover, the implications from other studies were that because the majority of
pharmacists acknowledged HIV as a serious risk to injecting drug users the sale
of injecting equipment was taken up (Jennings, 1977; Cuatt, 1989).

The other important factor that influenced many cu.rent sellers (48"/o) in this
study was that disruption was unlikely to occur. However the results show that
one third of pharmacists in the study have experienced such incidents and for past
sellers, disruption in the pharmacy and threatening incidents were the two

commonest factors influencing the discontinuation of supply. This was similar to
the fmdings in Greig's (1992) earlier studies which found that the major cause for
pharmacists ceasing to participate in Fitpack sales were fear of further assault,
break-ins and theft. Pharmacists used a range of strategies to handle disruptive

incidents, the commonest being verbal conciliation. However, a number had
difficulties and either ignored the incidents or used stronger measures. Only a
small minority of pharmacists have received any training in regard to selling
needles and syringes and it may be that this needs to be rectified.

Future Intentions
It is clear that the vast majority of pharmacists intend to continue to supply

needles and syringes to injecting drug users. However, there are some who
indicated that they may change their mind about selling practice. For example,
two sellers in the current study indicated that they intended to discontinue sales
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and another two were ambivalent about their selling practice. On the other hand
one of the nonsellers intended to sell on request and, although the other nonsellers
said they did not intend selling in the future, four qualified this by stating the
grounds that would encourage them to do so. There may therefore be some slight
fluctuation in selling practice but it seems unlikely that all pharmacists will
participate.

Fa<tors That DIITerentiate Current Sellers from Nonsellers

There was Jittle swprise in some of the results regarding the significant factors
that differentiated current sellers from nonselJers. That current sellers are more
likely to think that pharmacists should sell needles and syringes to help prevent
HIV and hepatitis C and injecting drug users should obtain needles and syringes
from pharmacies, and pay for them, is •elf explanatory. It terms of demographics

there were no differences between sel1ers and nonsellers except for the finding
that unemployed people were slightly more likely to be customers in current

sellers' pharmacies, though the relationship between these factors is unclear.

In addition, current sellers were more likely than nonsellers to believe both that
HIV was a serious health risk to injecting drug users and that the hazard posed by

the use of non-sterile injecting equipment was serious to injecting drug users.
However interpretation of these fmdings is a little difficult as the majority of
nonseiJers were past sellers.
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Disruptive Incidents in the Pharmacy
Possibly the most important factor differentiated between sellers and nonsellers
was that nonsellers (71%) were more likely than current sellers (27%) to have
experienced disruptive incidents in their pharmacy. This is reflected in the finding
that disruption in the pharmacy and incidents that threatened staff or other
customers were factors in the cessation of needle and syringe supply for the

majority of past sellers. OveraU, aggression and/or abuse were the most common
incident experienced by pharmacists and for nonsellers the possibility of

aggression is the commonest factor influencing their current reason for not selling.
It appears that support and/or training (previously alluded to) for pharmacists to
help deal with these incidents may be an option to consider.

HIV and Hepatitis C
Although the majority of pharmacists overall view HI V and hepatitis C as a
serious health risk to both the general public and injooting drug users, hepatitis C
is considered to be less of a risk than HIV for both groups, and while 93% of

both current and nonsellers think hepatitis C is a serious risk for injecting drug
users, more current se!Iers view it as very serious. These fmdings somewhat belie
the current infonnation on the prevalence of these diseases and their transmission.
Hepatitis C is at least five times more prevalent in Australia than HIV with at
least 15 times more new infections of hepatitis C each year (Wodak & Crofts,
1993). Moreover the incidence of hepatitis C among inje<1ing drug users is
extremely high with 80% to 90% of clients in the Perth methadone clinic infected
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with the virus (Kerry, 1994). Therefore transmission through the sharing of nonsterile injecting equipment is highly probable.

One possible explanation for Western Australian phannacists viewing hepatitis
C as a less serious health risk than HIV is that it is a more recently recognised
disease than HIV and has not been focused on to the same degree. Less education
regarding the disease has been forthcoming and this may need to be addressed.
On the other hand the result may be due to interpretation. It could be that

pharmacists considered the seriousness of the diseases compared to each other. If
that is the case then HIV, which almost certainly leads to AIDs and eventual
death, could be seen as more serious than hepatitis C, which although often
chronic and sometimes leads to death, has a far better prognosis. Were the survey

to be repeatc:d some thought would need to be given to rewording these questions.

Effects of the Legal Status
Although the sale of needles and syringes to injecting drug users was technically
illegal in Western Australia until May J994,just prior to the time data was
collected for this study, it had no significant effect on supply practice although
25% of sellers reported the impending legislative change was a factor in their
decision to start selling. Only 3 nonsel!ers (21%) considered it a factor in their
decision not to sell needles and syringes. In contrast, in Cuatt's (1989) Tasmanian
study 18 nonsellers (38%) cited their concern about the legalities of supplying

injecting equipment to injecting drug users as a reason they chose not to make
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needles and syringes generally available and 45% reported that a change in the
legislation would encourage them to supply.

Deterrence Theory.
It seems that the previous legal sanctions on the sale of injecting equipment to
drug users has not had a major impact in deterring sales in Western Australia. For

legal sanctions to be effective punishment must be certain, swift and/or severe
(Williams & Hawkins, 1986). The fact that needle and syringe supply was
condoned in Western Australia and that no prosecutions for sales had occurred
supports the theory of deteiTence. Indeed, for 40% of sellers the knowledge that

no prosecutions had been laid was an important factor in their decision to sell
Punishment was not certain, swift or severe as in the classic example of

deterrence namely RBT to reduce the incidence of driving under the influence of
w

alcohol (Home!, 1988). Punishment was in fact non-existent and with the
encouragement from the Health Department of Western Australia, the
Pharmaceutical Council and the Pharmacy Guild to sell needles and syringes and
the condonement of the practice the number of participating pharmacists has
continued to increase. Therefore, although a small minority of pharmacists

expressed some concerns about the legality of the practice it was not a deterrent
overall. Tasmanian pharmacists on the other hand, were in a dubious legal
position at the time of Cuatt's (1989) study as the practice was illegal and was not
condoned by the State Government, and there was less certainty thllt they would
not be punished, which may be a factor in their finding of only 21% supplying.
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Attitudes 1o Injecting Dnig Use and Injecting Drug UseJS
On average phannacists had slightly negative attitudes towards injecting drug use
and injecting drug users. As there was no significant difference between current
sellers and nonsellers it is apparent that many current sellers have put aside their
feelings towards injecting drug users and have adopted the goveromenfs IJllffil
reduction strategy in the interests of public health. While MacCarthey (1994)
claimed widespread discrimination of injecting drug users in Australia and that
they generally experience a poor response from a wide range of service providers
it appears this is not the case in tltis instance, at least as far as the supply of
needles and syringes goes.

The findings are similar to those of Abed and Neira-Munoz (1990) who found
that the majority of general practitioners were prepared to help drug dependents

despite having negative attitudes towards them on a number of counts. There are
differences between these situations, however, in that phannacists have been
asked to engage in an illegal activity to help prevent the transmission of serious
blood-borne disease, not only to the drug user but also from them to the general
community, and the general practitioners in Abed and Neira-Munoz' study are
asked about their willingness to treat drug dependence, a far less controversial
activity.
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Condusions

The vast majority of both metropolitan an-i country pharmacists in Western
Australia currently supply needles and syringes to injecting drug users thereby
ensuring availability in most areas of the state. Pharmacists generally have
adopted the practice because they believe it is essential to the reduction of the
transmission of disease. which is consistent with the trend found in other studies.
Although 8% of pharmacists were past sellers this proportion compares favourably
with the findings in other states indicating that less pharmacists in Western
Australia have ceased supply. However it appears that the proportion of
participating pharmacists will fluctuate slightly and it is unlikely that th "re will be
total participation.

While the belief that disruption was unlikely to occur in their pharmacy
influenced almost half of current sellers in their decision to supply, this was not
borne out by the experience of one third of the total pharmacists and indeed,
along with tlrreatening incidents, was the major cause for past sellers to cease
supply. Disruptive incidents were also the most important factor that differentiated
between current sellers and nonsellers with nonsellers experiencing significantly
W3

more. The incidence of such incidents and the effect that they have on supply
practice may indicate the need for support or training for pharmacists, especially
in view of the fact that aggression and/or abuse is the major type of incident and
many pharmacists seem to not have appropriate strategies for handling the
disruption. Further research may need to be earried out to determine whether
phannacists require support and/or training for conducting their business in
relation to the supply of injecting equipment.

HIV and hepatitis C were both viewed by pharmacists as serious diseases
although hepatitis C to a lesser extent. There was some difficulty inteJpreting this
data but there may be some implications for more education generally concerning
the greater possibility of the transmission of hepatitis C.

While phannacists on average had slightly negative attitudes to injecting drug use
and injecting drug users, this had not significantly affected supply practice which
may reflect pharmacists' commitment to public health. Pharmacists also were not
unduly influenced by the former legal sanctions on the sale of needles and
syringes and these findings could be viewed as supporting the the01y of
deterrence.

It is not known how representative this sample is of the wider population of
pharmacists, however the random sampling technique and the high response rate
would have enhanced it and the findings in many ways reflect the trends in
~imilar

studies
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APPENDIX A
POISONS ACT 1964
Form 14

APPLICATION FOR APPROVAL OF NEEDLE AND SYRINGE PROGRAM
I ...........................................................................................of.. ............... .

.................................................. hereby apply on behalf of .................... .
for the approval of the following needle and syringe program .................... :........................................ .

······························································································································································
(specify preclse(IJ Ihe octil•iries, and the person:r or doss ofpersons conducting /host aCiivilie.~. that conslitutt the
program).

1.

The program v.rill be conducted at ............................................................................................... .

........................................................ ................................................... ............................................... ..
(specify place or places)

The program v.rill be conducted at or between the following times .......

2.

................................................................... ........................... ................. ············· .......................... .
(specijj·fimes)

The Co-ordinator of the program will be ............................................... ..

3.

(specify namt and address ojCa-ordinatar)

Signature of Applicant

Signature of Co-ordinator
Date:
Note:

I) Return to:

Medical Co-ordinator
Communicable Disease Control Unit
PO Bo>: 8172

Stirling Street
PERTH WA 6000
2) For more infonnation

contact:

Ms Kathryn Kerry
(09) 227 3777
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APPENDIX~
The PHAR:'<!ACY GUILD of AUSTRALIA
NATIONAL SERVICES

Facsimile Transmission
DATE:

JULY71994

TO:

J. NEWBEY

HEALTH & HUMAN SERVICES DEFT. EDITH COWAN UNIVERSITY
FAX:

(09) 227 7302

f:'ROM:

Murray Aees- Direclor of National Services Division

PHONE:

(03) 810 9930

FAX:

(03) 818 2590

AE:

Survey No. 151

___________

_______

Number of pages including
cover sheet: 2
,,,,,.,.,._,,.

Message
Dear June.
Please find our survey certificate following.
PI east::: use it to convey to our members, our approval of your study. Should you consider that any key
findin~s may be of into:rest to our 5000+ members then we would be glad to distribute/publish them
when~ possible.
·

Thank you for involving Th!. Pharmac)· Guild of Australia.
Good l~ck \\1 ~r research.

Regard~#

c.c.

:\1r H. \V. G. Cuthill- Chainnan
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§lJ[JR.VJEY cCJEJR-1fJ[]!?J[(CA1rlB

No ... 151..

THE PHARMACY GUILD OF AUSTRALIA
This is to certify that the documentation for the following
survey has been presented for examination and that the Guild
has no objection to member participation
CONDUCTED BY:

J. NEWBEY- HEALTH & HUMAN SERVICES DHPT. EDnH CO \VAN UNIVERSID'

FOR (CLIENT):

AS ABOVE

PERIOD OF FIELD WORK: JULY TO AUGUST
METHOD OF SURVEY:

MAIL

STATES/AREAS TO BE COVERED:

RATING:

WESTERN A USTRAL!A

I

Bl

I

Signature of Approving Officer: ......................................................................... Date: JULY 61994
PLEASE NOTE: The Pharmacy Guild of Auslralia has examined lhe proposed qucsli ns to be i.lskcd in this survey and has gh•cn approval fur
.members to be tpproache.d about the survey. Such approval does not obligme any phmmt~cisi/Guild member to p:trlicipalc in the ~un•cy. The
:tHmice of whether or no{ ro participate is left to Ihe individual.

APPENDIX C
Initial Telephone CaD

Hello, may I speak to .......... please?
This is June Newbey from &lith Cowan University. We are currently
conducting a state-wide study of pharmacists' attitudes and practices in relation to
the supply of needles and syringes to injecting drug users. You are one of only
130 pharmacists selected to take part.
This phone call is to inform you of the study which entails completion of a
questionnaire which I will forward to you. The study and the questionnaire have
been discussed with both the Pharmaceutical Council of WA and the Pharmacy
Guild.
To ensure the results of the survey are genuinely representative of Western
Australian pharmacists your participation is iroportant and valuable. You may be
assured that the information you supply will be confidential. May I forward a
questionnaire to you.

H Yes: Thank you for your cooperation. I will post the questionnaire and a

stamped addressed envelope to you within the next day or two. I would appreciate
it if you could complete the questionnaire and return it within the next two weeks.
Finally, could you please tell me whether you currently supply needles and
syringes to injecting drug users? Thank you. Goodbye.

H No: Could you please tell me the reason you do not wish to participate?

One fmal thing, do you currently supply needles and syringes to injecting drug
users? Thank you for your time. Goodbye.
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APPENDIKD
THE SUPPLY OF NEEDLES AND SYRINGES
TO INJECTING DRUG USERS:
ATTITUDES AND PRACTICES OF PHARMACISTS
IN WESTERN AUSTRALIA

SURVEY OF WESTERN AUSTRALIAN
PHARMACISTS

EDITH COWAN UNIVERSITY
2 Bradford Street
Mount Lawley WA 6050

SURVEY OF WESTERN AUSTRALIAN PHARMACISTS
Thank you for your assistance in this endeavor. The following
questionnaire contains 43 brief questi0ns related to the
provision of needles and syringes.
"Your pharmacy" refers to the pharmacy in which you are
currently located. "Injecting drug users" are individuals
known or believed to be injecting drugs illicitly.
Please answer ALL questions.
(Unless specified please circle only one number represent.l.ng

the answer you most agree with).

PUBLIC HEALTH

The first set of questions concern public health issues in
Western Australia. We'.d like to know your thoughts on. these
matters. (Please circle one number on each scale).
1.

How serious a health risk to the general public do
you believe the HIV virus is in Western Australia?
Not '~~~~~-~----~·'------~·~~----5
at all
Not very
Unsure
Serious
Very
seriouo
serious
serious

2.

How serious a health risk do you believe the HIV virus
is for injecting drug users in western Australia?
';:--7;;--;:;;:;:-2--------o~'::::::-----o:::-:'=::--ucs
Not at
all
Not very
Unsure
Serious
Very
serious
serious
serious

3.

How serious a health risk to the general public do you
believe Hepatitis C is in Wester!l Australia?
2
Not ~t c,-,.,,,--,N-oc-t vce-ry=---ouo-n;'ucrc-e---,s=-ec:ious'----v~;ry
serious
serious
serious

4.

How eerie·"• a health risk do you believe Hepatitis C

is to injecting drug users in Western Australia?
Not ~:;t-a"l"l;--;;N;-:o-;:-t v::e=-ry~--"u""n;·~ur:::e:-----,S::-e:::i"o=u"s:---,-v~'ry
serious
serious
serious

2
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5.

Do you think that the use of .non sterile injecting
equipment by injecting drug users represents a
significant health hazard to the general public?
1

2

Not at all Not very
significant significant

6.

'=--::=,4

Unsure

Significant

Do you think the use of non-sterile injecting
equipment by injecting drug users represents a
significant health hazard to injecting drug users?
l:;-:=-;;::;-·2=::--='=--;;,=4
Unsure
Significant

Not at all Not very
significant significant

7.

5

Very
significant

5

Very
significant

What role do you think pharmacists should play in
relation to the prevention of HIV and Hepatitis? (More
than one number may be circled).
1
2

6

Provide advice, information and counselling.
Provide information and pamphlets on HIV, Hepatitis
and injecting drug use.
Sell needles and syringes to injecting drug users.
Sell condoms.
Provide free sterile needles and syringes on receipt
of used equipment.
Pharmacists should play no role.

7

Other (Please specify) __~---------------------------

3

4
5

NEEDLE AND SYRINGE DISTRIBUTION
The next set of questions. concern the distribution of needles
and syringes to injecting drug users.
8.

Where do you think injecting drug users should obtain
needles and syringes from? (More than one number may
be circled) .

1
2
3
4
5
6
7
8
9
10
11

Hospitals
Drug treatment agencies
Pharmacies
Police Stations
Doctors' surgeries
Community Health Centres
Outreach vans
Needle Exchanges
Vending Machines
None of the above
Needles and syringes should not be supplied to
injecting drug users.

12

Other (Please specify)
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9.

.....:.......

How do you think needles and syringes should be SuPplied
to injecting drug users? (More than one number may be
circled).

1
2
3
4

10.

Injecting drug users should buy needles and
syringes.
Injecting drug users should exchange used needles
and syringes for new equipment.
Needles and syringes should be supplied free to
injecting drug users.
Needles and syringes should not be supplied at all
to injecting drug users.

Does your pharmacy have a policy regarding the sale of
needles and syringes to injecting drug users?
1
2

Yes
No

If Yes:
lOa. What are the main pointa o£ your policy regarding
the sale of needles and syringes to injecting drug
users?

11.

Have you had any training regarding the sale of needles
and syringes to injecting drug users?
1
2

Yes
No

I f Yes:

lla. In what year did you have training regarding the
sale of needles and syringes to injecting drug
users?

Year_____
llb. Which organisation conducted the training regarding
the sale of needles and syringes to injecting drug
users?
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12.

Do you support the Health Department of Western
Australia 1 S strategy to encourage pharmacists to sell
needles and syringes to injecting drug users for harm
minimisation reasons?
2

Yes
No

CURRENT PRACTICES
Now we would like to know about your practices in relation to
the supply of needles and syringes. The following questions
relate to the pharmacy in which you are currently located.
13.

When did you begin to supply needles and syringes to
injecting drug users?

·Year

Month

14.

How important were the following in determining your
decision to start selling needles and syringes to
injecting drug users? (Please circle one number on
each scale).
14a. I became more convinced the that supply of needles
and syringes was essential for the reduction of
transmission of disease.
1

Not at all
important

2

Not very
important

3 ,.--c,---~=.,.·

Neutral

Important

5

Very
important

14b. It became clear that the legislation was going to
change.
1

Not at all
important

2

Not very
important

3

Neutral

4

Important

5
Very

important

14c. It became clear that disruption to my pharmacy was
unlikely to occur.
2
Not ~:-t--,a-,1"'"1-"""N'""o""t v ery•=--""'N"e""u·~"ra"1;---,Im=p=-oc:·:-ta"n7t--"v"'e0
important
important
important
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14d. It became obvious that no-one was being prosecuted
for selling needles and syringes.
Not ~;:-t-=a"r'r--;:;N;::o;:-/::ve:::ry:::---;;N;::e::-u.~·=r:-a,,--c;rm=p=o:-·:tan t
important
important

Ve ~
important

14e. I saw the provision of needles and syringes as a
viable commercial practice.
1
Not at
all
important

Not 2very
important

'~-~~:::·
Neutral
Important

5
Very
important

14f. Other reasons (Please specify)

15.

How do you usually sell needles and syringes?

1
2

16.

In Fitpacks
Other (Please specify)

Approximately how many Fitpacks/needles do you sell in
a typical week?

Fitpacks

Needles
Other

17.

How much do you charge for Fitpacks/needles?

Fitpacks

$ _ _ _ __

Needles

$ _ _ _ __

Other

$_ _ __
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18.

Have you experienced a disruptive incident in your
pharmacy concerning injecting drug users?
1

2

No

(Go to Q 19)

Yes (Please specify) __________________________

lSa. How did you handle the disruptive incident?

18b. Has the disruptive incident influenced your practice
of selling needles and syringes to injecting drug
users in any way?
1
2

Yes
No

I f Yes:

18c. In what way has this influenced your practice of
selling needles and syringes to injecting drug users?

19.

Have you experienced any/any other problems in your
pharmacy as a result of selling needles and syringes to
injecting drug users?
1
2

No

Yes

(GotoQ20)
(Please specify) _____________________
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If Yes:
19a. Has this influenced your practice of selling needles
and syringes to injecting dJ:-ug users in any way?
1

Yes

2

No

I f Yes to 19a:

19b. In what way has this influenced your practice of
selling needles and syringes to injecting drug users?

20.

Do you intend to continue to supply needles and syringes
to injecting drug users in the future?
1
2

Yes
No

If No:

20a. What are the reasons for your decision to no longer
supply needles and syringes to injecting drug users?

21.

Are you currently involved in dispensing methadone?
1

Yes

2

No

If Yes:

21a. How many clients do you currently supply with
methadone?
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LEGISLATION
This section focuses on issues related to current legislation
and how it impacts on your practices.
22.

What is the current legal status regarding the sale of
needles and syringes to injecting drug users?

23.

In what way has this inflUii!nced your practice regarding
the sale of needles and syringes to injecting drug users?

ATTITUDES TO INJECTING DRUG USE AND INJECTING DRUG USERS.
This section concerns your attitudes to injecting drug use and
injecting drug users. (Please circle one number on each scale).
24.

Injecting drug users are mindless pleasure seekers.

Str~"'ng='lC:Cy:---,-A:::g:~:-ee=----;u;:n-::s·~·=re=---;oocic:s:::a~-::re::e:---;S;;:t::r~ngly
Agree

25.

Disagree

Injecting drug use is simply a different kind of lifestyle that should not be condemned.
St r~=-ng='l;:-y:---;A:::g~:-ee=----;u;:n-::s~' =r:-e----,D"'i"s"a ~=-re::e:---;S:::t::r~ng ly
Agree

26.

Injecting drug users are not capable of changing.
1

Strongly
Agree

27.

Disagree

2

Agree

3

Unsure

4

Disagree

5

Strongly
Disagree

Injecting drug users are criminals by nature.
1

Strongly
Agree

2

Agree

3

Unsure

,.

4

Disagree

5

Strongly
Disagree
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28.

If a person craves drugs they should overcome this by
sheer willpower.

Str~ng'ly~--~A~g;~••=-----~U~n~s:~~r~e----~D~i~scca~~r~e~e----~s~t"'r~ngly
Agree

29.

Disagree

Injecting drug users should be allowed to inject in
private.

Str~-n~g~lyc----c,,-g;~••c-----~U~n-s~~r=e----~D~i~sCOa~~r=e=e----~S~t:::r;ngly
Agree

30.

Dis.Jree

It is a waste of time trying to help injecting drug users.

Str~~n~g~lyc----cAc=g:=e~e----~U~n~s:~=r~e----~D~i~scca~Lr~e~e----~S~t'"r;ngly
Agree

31.

Disagree

If injecting drug use was legal it would not be a problem.

Str~-n~g~lyc----c,,-g;~.~.----~u~n~s·~~r-e----~D~i~s-a~'-r-e~e----~s~t-r~ngly
Agree

32.

Disagree

Injecting drug use is just plain WTong.

Str~-n~g~lyc----cAc-g;~.~.----~u~n~s:~~r-e----~D~i~s-a~'-r-e~e----~s~t-r;ngly
Agree

33.

Disagree

Injecting drug use is a natural way of obtaining pleasure
in human beings.

Str;n~g~l~yc----A~g==;.~.=-----~u~n'"s;r~ec---~D~,~·s~a~g~=e~ec---~st~r'";ngly
Agrea

Disagree

DEMOGRAPHIC DETAILS
Finally we would like to ask some questions about yourself and
your pharmacy for statistical purposes.
34.

In what year did you register as a pharmacist?
Year
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35.

How long have you been working as a

ph~rmacist?

Years -----------36.

How long have you been in the present pharmacy?
Months

Years

37.

What is your present age?

38.

Which sex are you?
1
2

Male
Female

39.

How many equivalent full time staff are employed at your
pharmacy?

40.

From the following list of examples which best describes
the location of your pharmacy?
1

2
3

4
5
6

41.

Central Business District
Regional Shopping centre
Strip type shopping
Neighbourhood shops
Isolated
Other (Please specify) _________________________

What are the opening hours of your pharmacy?
Monday
Tuesday
Wednesday
Thursday
Friday
Saturday
Sunday
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42.

What is. the largest customer group served by your
pharmacy? (More than one number may be circled).
1

Unemployed

2
3

Passing trade
Professionals/Office workers

4
5

Students
Elderly

6
7

Young families
"Alternatives"
Other (Please specify)

8

43.

What is your postcode?

Do you have any further comments on the issues in this
questionnaire or suggested strategies that might be useful for
pharmacists in dealing with injecting drug users?

Please tick the box if you would like a summary of the findings
from this study.

0
could you please now place the questionnaire in the stamped
addressed envelope provided and return to Edith Cowan
University.

THANK YOU VERY MUCH FOR YOUR COOPERATION
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APPENDIX E
THE SUPPLY OF NEEDLES AND SYRINGES
TO INJECTING DRUG USERS:
ATTITUDES AND PRACTICES OF PHARMACISTS
IN WESTERN AUSTRALIA

SURVEY OF WESTERN AUSTRALIAN
PHARMACISTS

EDITH COWAN UNIVERSITY
2 Bradford Street
Mount Lawley W A 6050
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SURVEY OF WESTERN AUSTRALIAN PHARMACISTS
Thank you for your assistance in this endeavour. The
following questionnaire contains 40 brief questions related to
the provision of needles and syringes.
"Your pharmacy" refers to the pharmacy in which you are
currently located. "Injecting drug usersu are individuals
known or believed to be injecting drugs illicitly.

Please

answer~

questions.

(Unless specified please circle only one number representing
the answer you most agree with).

PUBLIC HEALTH
The first set of questions concern public health issues in
Western Australia. We would like to know your thoughts on
these matters. (Please circle. one number on each scale}.
1.

How serious a health risk to the general public do you
believe the HIV virus is in Western Australia?
Not ~t all
serious

2.

How serious a health risk do you believe the HIV virus
is for injecting drug users in Western Australia?
Not ~t all
serious

3.

2

Not v'"e::ry:::---;-;un=-·;:u::r::e;--~s::ce;',-io=u::s;---,.,V;ry
serious
serious

2
Not ·v"e-ry,----;-;U-n;u,-r-e---=s-e;',-;o::u-s--"'7.'V;ry
serious
serious

How serious a health risk to the general public do you
believe Hepatitis c is in Western Australia?
Not ~t=-=a"l"l--;N:;:o::t,.-·v':::e=ry::----,.,un::;.u~r=e:---csoce::~:i;-:o:cu:::s---;vc;;cry
serious
serious
serious

4.

How serious a health risk do you believe Hepatitis c is
to injecting drug users in western Australia?
Not ~t all
serious

2

Not v·"e'"'ry,----;-;Uccn:u•~r"'e:--.---s"e~:·,,.,.o"'u"'s---,v~;·ry
serious
serious
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5.

Do you think that the use of non sterile injecting
equipment by injecting drug users represents a
significant health hazard to the general public?
1
2
Not at all Not very
significant significant

6.

'~--~~~··

Unsure

Significant

5
Very
significant

Do you think the use of non-sterile injecting

equipment by injecting drug users represents a
significant health

hazard to injecting drug users?

Not 1_
at all Not 2very
significant significant

7.

'=----;=::o''
Significant

Unsure

5
Very
significant

What role do you think pharmacists should play in
relation to the prevention of HIV and Hepatitis? {More
than one number may be circled).
1

Provide advice, information and counselling.

2

Provide information and pamphlets on HIV, Hepatitis
and injecting drug use.
Sell needles and syringes to injecting drug users.
Sell condoms.

3
4
5

Provide free sterile needles and syringes on receipt
of used equipment.
Pharmacists should play no role.

6

7

Other (Please specify) ______________________________

NEEDLE AND SYRINGE DISTRIBUTION
The next set of questions concern the.distribution of needles
and syringes to injecting drug users.
8.

Where do you think injecting drug users should obtain
needles and syringes from?
(More than one number may
be circled).

1
2
3
4
5
6
7
8

Hospitals
Drug treatment agencies
Pharmacies
Police Stations
Doctors' surgeries
Community Health Centres
Outreach vans
Needle Exchanges
Vending Machines
None of the above
Needles and syringes should not be suppli-...d. to
injecting drug users.
Other (Please specify)

9
10
11
12
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9.

How do you. think needles and syringes should be supplied
to injecting drug users? (More than one number may be
circled).

1
2
3
4

10.

Injecting drug users should buy needles and
syringes.
Injecting drug users should exchange used needles
and syringes for new equipment.
Needles and syringes should be supplied free to
injecting drug users.
Needles and syringes should not be supplied at all
to injecting drug users.

Does your pharmacy have a policy regarding the sale of
needles and syringes to injecting drug users?
1
2

Yes
No

If Yes:
lOa. What are the main points of your policy regarding
the sale of needles and syringes to injecting drug
users?

11.

Have you had any training regarding the sale of needles
and syringes to injecting drug users?
l

Yes

2

No

I f Yes:

lla. In what year did you have training regarding the
sale of needles and syringes to injecting drug
users?
Year_ _ _ __

llb. Which organisation conducted the training regarding
the sale of needles and syringes to injecting drug
users?
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12.

Do you support the Health Department of Western
Australia's strategy to encourage phar.macists to sell
needles and syringes to injecting drug users for harm
minimisation reasons?
1

Yes

2

No

CURRENT PRACTICES
Now we would like to know about your practices in relation to
the supply of-needles and syringes. The following questions
relate to the pharmacy in which you are currently located.

13.

Do you sell needles and syringes to customers other than
those you know or believe to be injecting drugs
illicitly?
1
2

Yes
No

I f Yes:

l3a. How do you differentiate between injecting drug
users and other customers in your pharmacy?
(More than one may be circled)

4
5

Appearance
Behaviour
Direct questioning
Reasons given for requiring syringes
'Gut' feeling

6

Other (Please specify)

1

2
3

14.

Do you intend to supply needles and syringes to injecting
drug users in the future?
1
2

Yes
No

I f yes:

l4a. For what reason do you intend to change your current
practice in relation to supplying needles and
syringes to .injecting drug users?
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15.

Have you sold needles and syringes to injecting drug
users in the past?
1

Yes

2

No (Go to Q 16)

If yes:
15a. When did you stop selling needles and syringes to
injecting drug users?
Month----

Year-----

15b. Have you experienced a disruptive incident in your
pharmacy concerning injecting drug users?
1

2

i.

(Go to Q 15c)
Yes (Please specify) __________________

No

How did you handle the disruptive incident?

ii. Did the disruptive incident influence your practice

of selling needles and syringes to injecting drug
users in any way?
1

Yes

2

No

I f Yes:

iia. In what way did this influence your practice of
selling needles and syringes to injecting drug
users?
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lSc. Were the following factors important in your
decision to stop selling needles and syringes to
injecting drug users? (Please circle one number on
each scale).
i.

Selling needles and syringes had caused disruption
in my pharmacy.
Not ~t all
important

2
Not v:-e:-:ry:-:---::Ne"u:c:'ccra'"l,---o;-Im"'p"o=-':tant
important

Ve~
important

ii. I was losing too much stock from shoplifting.
Not ~:-t--:a:-;lc;l--,No;co::;tc''v:-e::ry:cc---;;N:::eu:C:'::-ra:Cl;--o;-Im"p"'o::::-ta::n:;t:----;;V;:::e~
important
important
important

iii. There were incidents that threatened the safety of
staff and/or other customers.
Not ;t all
important

2
Not v:-e:-:ry:-:----;;N:ceu::-::'=ra;cl,----,Im=-po=-:tant
important

Ve~
important

iv. I was concerned about the legal ramifications.
Not ; t all
important

v.

2
Not v"'e::ry:cc---;;N:::eu"':'::-ra:cl,---.,-,m::-p:co::--::-ta::n:;t:----;;V;:::e~
important
important

I had ethical concerns about appearing to condone
illicit drug use.
1 all
Not at
important

'=::-----,=,''=-----;:=·
Neutral
Important

Not very
important

5
Very
important
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vi. I was concerned about the local community's attitude
relating to the supply of needles and syringes to
injecting drug users.
2

Not ~~t-a=-1"1;-~N=-=o7
t ~vc"ery=--,N"'e"'"'u~r-a"1;---=rm-p::-o-:·t""a-n"'t---,Vc-e;,
important
important
important

vii. Other (Please specify)

(Please answer question 16. Although you will find it vezy
similar to the questions you just answered it is also
important that we investigate your current reasons for not
selling needles and syringes to injecting drug users).

16.

How important are the following factors in determining
your current decision not to sell needles and syringes
to injecting drug users? (Please circle one number on each
seal e) .
16a. Provision of needles and syringes encourages illicit
drug use.
Not ;t all
important

2
Not v::-e"ry,_---,N:-:eccu:;r-a"1;---,I:-:m::-p-,o:·tant
important

Ve~
important

16b. I am concerned about shoplifting in my pharmacy.
Not ;t all
important

2
Not v::-e:-:ry,-----oN:-:eccu;·r-a"1;---,I:-:m::-p-,o:tant
important

Ve~
important

16c. I am concerned about possible aggression towards
staff of the pharmacy.
Not ;t all
important

Not v~e"ry=c-~N:-:e~u;~r=a::-1;--~I~m=p"'-o:tant
important
2

Ve~

important
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l6d. Because of the current legislation on the supply of
needles and syringes.
1
Not at all
important

2'=-~~.3-,.--=-·4
Not very
Neutral
Important
important

5
Very
important

16e. MY other customers would complain or stop coming to
the pharmacy if I sold needles and syringes to
injecting drug users.
Not ~t a 11
important

2
Not v-:ce::ry:::----,N:-eu"'g'::r:-a1;---=rm=p=-o:::·t=-a::n::t:----;,v"'e;,
important
important

16f. I don•t want the kind of people who use drugs coming
into my pharmacy.
Not .;t.,.-a,-l~l;----,N,-o7
t 'v-:-ec-ry--7N""e-ug'r--al;---:I,-mp-o-:t::a-n::t--~Vc-e;,
important
important
important
2

l6g. I have not had any requests for needles and syringes.
2
Not ~t,--a,-1~1;----,N::o:::-t '·vc-=-e=ry::---oNo-eccu;'=r:-a"'l---;I=mp:-o:-:.:-ta"n"t:---;cVcce;,
important
important
important

16h. I am concerned about being prosecuted for providing
needles and syringes.
'-.,-,-~=2'--~,--'',--,,---,-4,--.,---.,.,--s
Not at all
Not very
Neutral
Important
Very
important
important
important

l6i. Other (Please specify)

17.

What would encourage you to sell needles and syringes to
injecting drug users?
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18.

Are you currently involved in dispensing methadone?
1

Yes

2

No

I f Yes:

l8a. How many clients do you currently supply with
methadone?

LEGISLATION
This section focuses on issues related to current legislation
and how it impacts on your practice.
19.

What is the current legal status regarding the sale of

needles and syringes to injecting drug users?

20.

In what way does this influence your practice regarding
the sale of needles and syringes to injecting drug users?

ATTITUDES TO INJECTING DRUG USE AND INJECTING DRUG USERS
This section concerns your attitudes to injecting drug use and
injecting drug users. (Please circle one number on each scale).
21.

Injecting drug users are mindless pleasure seekeriL

Str;=n""g"ly::---;;-Ag=·;-oee:----;-u;::n"s~"re:---,D::ic:s"a~·=r-=ee=---;;;s,cr~ngly
Agree

22.

Disagree

Injecting drug use is simply a different kind of lifestyle that should not be condemned.

str;""ng~l""y,.---cA"g;.,-ee=-_---,u==n=s~=re=---,o"i"'s"a~·=r-=-ee:---cso:t=~~ngly
Agree

Disagree
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23.

Injecting drug users are not capable of changing.
1

Strongly

2

Agree

3

Unsure

4

Disagree

A£:;:..·ee

24.

5
strongly

Disagree

Injecting drug users are criminals by nature.

str~=n=g"lyc.---~A~g~r=e=e----~u~n:::s:~=r=e----~D~i~s"'a~=r=e=e----~s~t"'r;ngly
Agree

25.

Disagree

If a person craves drugs they should overcome this by
sheer willpower.

Str;=n=g"lyc---~A~g:~~.=.----~U~n~s•~-r=e----~D~i=s--a~-r=e-e_____S~t--r~ngly
Agree

26.

Disagree

Injecting drug users should be allowed to inject in
private.

Str;-n-g7lyc---A=g-·~=ee;:------;u;:n:::s:~=r=e-----;D~i"s"'a~·=r=e=e-----:S;;tc:r~ngly
Agree

27.

Disagree

It is a waste of time trying to help injecting drug users.

Str;::n::g.,-lyc.----A.,-g::~:e::e----~U;:n:::s:~::r::e-----;D~i-=s::ca~·=r=e=e-----;S;;tc:r;ngly
Agree

28.

Disagree

If injecting drug use was legal it would not be a problem.
Str;-ng~ly----~A-g;-.-.----~u~n~s•~-r-e----~D~i-s-ca~-r-e_e_____S~t--r;ngly
Agree

29.

Disagree

Injecting drug use is just plain wrong.

str;=ng=lyc---~,-,-g·;-.=.----~U~n~s•~=r=e----~D~i"s-=a~=r=ee,---~s=rr=;•ngly
Agree

30.

Disagree

Injecting drug use is a natural way of obtaining pleasure
in human beings.

Str~n~g~l~Y,---~,=:g;e::ec-----u~n~s~~r~e~---;D~l~·s::a~g~=e::ec---~s~tr:::ngly
Agree

Disagree
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DEMOGRAPHIC

DE~AILS

.

Finally we would like to ask some questions about yourself and
your pharmacy for statistical purposes.
31.

In what year did you graduate as a pharmacist?
Year -------------

32.

How long have you been working as a pharmacist?
Years

33.

How long have you been in the present pharmacy?
Years

Months

34.

What is your present age?
Years

35.

Which sex are yet•?
1

2

Male
Female

36.

How many equivalent full time staff are employed at your
pharmacy?

37.

From the following list of examples which best describes
the location of your pharmacy?
1
2
3
4
5

6

central Business District
Regional Shopping Centre
Strip type shopping
Neighbourhood shops
Isolated
Other (Please specify) _________________________
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38.

What are the opening hours of your pharmacy?
Monday
Tuesday
Wednesday

Thursday
Friday
Saturday
Sunday

39.

What is the largest customer group served by your
pharmacy? (More than one may be circled).
1
2
3

4
5

6
7

B

40.

Unemployed
Passing trade
Professionals/Office workers
Students
Elderly
Young families
"Alternatives''
Other (Please specify)

What is your postcode?
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Do you have any further comments on the issues in this
questionnaire or suggested strategies that might be useful for
pharmacists in dealing with injecting drug users?

Please tick the box if you would like a summary of the findings
from this study.

D
Could you please now place the questionnaire in the st~ped
addressed envelope provided and return to Edith cowan
University.

THANK YOU VERY MUCH FOR YOUR COOPERATION
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APPENDIXF
~BE SUPPLY OF
A~~I~UDES AND

NEEDLES AND SYRINGES ~0 INJEC~ING DRUG USERS:
PRACTICES OF PBARMACIS~S IN WES~ERN AUS~RALIA
PRE-~ES~

OF

QUES~IONNAIRE

Thank you for agreeing to participate in the pre-testing of
this questionnaire. This is one of two questionnaires
developed, one of which will be forwarded to pharmacists
depending on their supply practices. A preceding telephone
call to pharmacists will determine this. It is the purpose
of this pre-test stage to determine the time the
questionnaire takes for completion and the clarity of the
questions. No further questions will be included but
adjustments will be made where necessary.
Please answer questions by adopting the role of seller,
non-seller or past seller as indicated on the top of the
questionnaire.
Time to complete -----------Please comment on any difficulties, ambiguities etc., you
found with any of the questions. Suggestions for
improvement of the questionnai~e are also welcome.

Please write on back of the page if you have further
comments.
Your assistance is very much appreciated. Thank you.
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Ne
_1

Name
ITown

3

Town

17 Long Street
i

i

:£f

:=IN :

PhonoNo
09123456 IFred

·phCaJI ~

o~~IJoeCool

IShoo 5, Town
i

09

I

-~
5
6

8

~"'"'

16

11
i9
2C

This form was made on a spreedsheet and was printed on continuous computer
paper so that the print on the two pages almost met The pages were taped at the

back on the join and this enabled a view of each record across the two pages.

--

-

. •,

Qu Seller Posted

·

_____

-

_......._

~

-."'..
--

Due

R'c-:ed Fol'up

Qu Posted R'slts Posted

Comments

EDITH COWAN
UNIVERSITY
PERTH WESTERN AUSTRALIA
JOONOALUP CAMPUS

APPENDIX H

Joondalup Drive. Joondalup
Western Australia 6027
Telephone (09) 405 5555
Facsimile (09) 300 1257

Dear
RE:

THE SUPPLY OF NEEDLES AND SYRINGES TO INJECTING DRUG
USERS: ATTITUDES AND PRACTICES OF PHARMACISTS IN WESTERN
AUSTRALIA.

In Western Australia, the supply of needles and syringes to injecting drug users
by pharmacists, and pharmacists attitudes about these issues has not been
extensively examined. The purpose of the present study is to investigate these
issues, anti provide you with an opportunity to voice your own views.
One hundred and thirty pharmacists from Western Australia have been
randomly selected to take part in the study. In order that the results be
genuinely representative it is important that each questionnaire be completed
and returned. Your input is both valuable and appreciated.
You may be assured of complete confidentiality. The questionnaire has an
identification number for mailing purposes only. This is to check your name off

the mailing list when the questionnaire is returned. Overall results will be
collated, but individual respondents will not be identified.
A summary of the findings will be made available to both the Pharmaceutical
Council and the Pharmacy Guild. If you would like to receive your 0wn copy
please tick the box at the end of the questionnaire.
Please return the completed questionnaire in the stamped addressed envelope

by
If you have any questions please telephone June Newbey on (09) 445-2139 or
Celia Wilkinson (Edith Cowan University) on (09) 370-6329.
Thank you for y.,ur assistance in this research project.

Yours faithfully
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(09) 405 5555

t09) Ji06111

~H:~::z
Street Churchlands
r.AMPUS

CLAREMONT CAMPUS

P~arson

Goldswon~y Road. Claremont

Westcu~ Australia 6018
Td~p~one •i:·912i3 8333

Western Australia 6010
Tele~hone

t0912i3 8333

~NBURY
Rotmtson Duve. Bun bury
CAMPUS

western Australia 6230
Telep~one 1()97180 i777

M>PENDJX I

Fimt Follow-up Telephone Reminder Call

Hello, this is June Newbey speaking from Edith Cowan University.
I am calling regarding the questionnaire I forwarded to you concerning the supply
of needles and syringes to injecting drug users. Did you receive it?
H yes: As I haven't yet received it back I wonder whether you have had the

opportunity to complete it. I realize you may be vel)' busy so this is just a
reminder. Your answers are vel)' important to us and I would appreciate it if you
could return it as soon as possible.
If you require another questionnaire I will forward it to you. Thank you vel)'
much. Goodbye.

H No: I am SOfl)' it did not reach you. May I forwwd another questionnaire to

you?
HYes: Thank you. Could you please tell me your address so I can check that the

address I have for you is accurate. Thank you vel)' much. I will forward another
questionnaire tomorrow. I would appreciate it if could complete and return it as
soon as possible. Goodbye.
H no: Thank you for your time. Goodbye.
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APPENDIX J
Second Follow-up Telephone RemiDder Call

Hello. This is June Newhey from Edith Cowan University. As yet I have not
received the questionnaire I posted to you concemiDg the supply of needles and
syringes to injecting drug users.
Your answers are very important to ensure the results are representative of
phannacists' views. CouJd you please return the questionnaire as soon as possible?

Thank you ver; much for your assistance.
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EDITH COWAN
UNIVERSITY
PERTH WESTERN AUSTRALIA
JOONOALUP CAMPUS

APPENDIX K

Joondalup Drive, Joondalup
Western Australi~ 6027
Telephone {09) 405 5555
Facsimile (09) 300 1257

4/10/94

Dear

RE:

"TilE SUPPLY OF NEEDLES AND SYRINGES TO INJECTING
DRUG USERS: ATTITUDES AND PRACTICES OF PHARMACISTS
IN WESTERN AUSTRALIA"

We are writing to express our appreciation for your participation in the research
we are currently conducting regarding the supply of needles and syringes to
injecting drug users. The response received was overwhelming and indicates to
us the importance of this topic to pharmacists and the concern they have about
these issues. By completing and returning the questionnaire you have helped
ensure that the findings better represent the views of pharmacists in Western
Australia.
The data analysis is currently being undertaken and the research report prepared.
This is expected to be finalised towards the end of the year when your copy of the
results will be forwarded to you.
Thank very much for your cooperation in this important social research.
Yours faithfully,

June Newbey, Honours Student

Celia Wilkinson, Lecturer- Health Studies
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JOONOALUPCAMPUS
Joon!lalup Or Ne. Joondatup
Western Austra11a 5027

Telephone (09) 405 5555

MOUNT LAWLEV CAMPUS
2 Bradford Street. Mount Lawley
Western Australra 6050
Telephone 1091 370 6111

CHURCHLANDS CAMPUS
i'carson S!leel Churchlancls
Western At1srraha 5018
Telephone r091 273 8333

CLAREMONT CAMPUS
Goldsworthy Road. Claremont
Western Austra11a 6010
Telephone 109) 273 8333

BUNBURY CAMPUS
Drive. Bunbury
Western Austro:oa 6230
Telephone (097) BO 7777
Robert~on

EDITH COWAN
UNIVERSITY
WEfTERN AUSTRALIA

BUNBURY CAMPUSi

APPENDIX L

Robertson Drive, Buntmry
Western Australia 6230
Telephone (097) 81) 7777
Facsimile (097) 21 6994

4/10/94

Dear

RE:

''THE SUPPLY OF NEEDLES AND SYRINGES TO INJECTING
DRUG USERS: A TI1TUDES AND PRACTICES OF PHARMACISTS
IN WESTERN AUS1TtALIA"

We are writing to express our appreciation for your p•Iticipation in the research
we are currently conducting regarding the supply of needles and syringes to
injecting drug users. The response received was overwhelming and indicates to
us the importance of this topic to pharmacists and the concern they have about
these issues. By completing and returning the questionnaire you have helped
ensure that the findings better represent the views of pharmacists in Western
Australia.
The data analysis is currently bt.ing undertaken and the research report prepared.
This is expected to be finalised towards the end of the year when a copy of the
results will be made available to both The Pharmaceutical Council of Western
Australia and the Pharmacy Guild of Australia.
Thank very much for your cooperation in this important social research.
Yours faithfully,

Cella Wilkinson, Lecturer - Health Studies.
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JOONOALUP CAMPUS
Joon~alup

Drive. Joondalup
Weslern Australia 6027
Tel~phooe (09) 405 5555

MOurn LAWLEY CAMPUS
2 Bradford Street. Mountlawley
W~stern

Australia 6050

Telephone \09) 370 5111

CHURCHLANOS CAMPUS
Pearson Sireet, Ctwrchlancfs
Weslern Austral•a 5018

Telepllone {09)383 8333

ClARE MONT CAMPUS
Goldswor1hy Road. Claremon1
Western Austral:a 6010
Telephone 109) 3B3 0333

BUNBUAY CAMPUS
Aobertson Drive. Bunbury
Western Australia 6230
Telephone (097) BO 7777

EDITH COWAN
UNIVERSITY
PERTH WESTERN AUSTRALIA
JOONOALUP CAMPUS

APPENDIX M

Joondalup Drive, Joondalup
Western Australia 6027
Telephone (09) 405 5555
Facsimile {09) 3001257

4/10/94

The Director
National Services Division
Pharmacy Guild of Australia
40 Burwood Road
HAWTHORNE
Victoria 3122

RE:

"THE SUPPLY OF NEEDLES AND SYRINGES TO INJECTING
DRUG USERS: ATTITUDES AND PRACTICES OF
PHARMACISTS
IN WESTERN AUSTRALIA"

Dear Mr Rees,
The data gathering process in the above study has been concluded. The sample of
130 pharmacists selected to take part have shown ovenvhelming cooperation with
this project. A response rate of 89% has been achieved, an excellent return for a
survey of this kind. Such a response ensures that the findings will better represent
the views of Western Australian pharmacists.
Approval of the survey by The Pharmacy Guild helped legitimise the study and
was undoubtedly a very important factor in achieving this high response rate. The
assistance given by you and your organisation is very much appreciated and has
aided the smooth execution of the data gathering process.
The data analysis is currently being undertaken and the research report prepared.
This is expected to be finalised towards the end of the year when a copy of the
resuits will be forwarded to you.
Yours faithfuily,

C : : : : Z s Student
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Celia Wilkinson, Lecturer- Health Studies

JOQriOAlUP CAMPUS

MOUNT LAWlEY CAMPUS

Joondalup Dri1·e. Joondalup

2 Bradtord StreeL Motml Lawley
\Vestem Ausbillra 6050
Te'eph o~e ros·, 37 0 61 t 1

Westem Austr~t1a 6027
T~reoMne {09t ~05 5555
·-·-~--·-----

~--_c._,"

..----,- --- ----- _______

,--~

..........,....___
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4/10/94

Joondalup Drive, Joondalup
Western Australia 6027
Telephone (09) 405 5555
Facsimile (09) JOG 1257

The President
Pharmacy Guild of Australia
Hay Street
WEST PERTH 6004

RE:

"THE SUPPLY OF NEEDLES AND SYRINGES TO INJECTING
DRUG USERS: ATTITUDES I..ND PRACTICES OF PHARMACISTS
IN WESTERN AUSTRALIA"

Dear Mr Zafer,
The data gathering process in the above study has been concluded. The sample of
130 pharmacists selected to take part have shown overwhelming cooperation with
this project. A response rate of 89% has been achieved, an excellent return for a
survey of this kind. Such a response ensures that the findings will better represent
the views of Western Australian pharmacists.
Approval of the survey by The Pharmacy Guild helped legitimise the study and
was undoubtedly a very important factor in achieving this high response rate. The
assistance given by your organisation is very much appreciated and has aided the
smooth execution of the data gathering process.
The data analysis is currently being undertaken and the research report prepared.
This is expected to be finalised towards the end of the year when a copy of the
results will be forwarded to you.
Yours faithfully,

June New bey, Honours Student

Celia Wllkinson, Lecturer- Health Studies
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APPENDIX 0

Joondalup Drive, Joondalup
Western Australia 6027
Telephone (09) 405 5555
Facsimile (09) 3001257

The Registrar
Pharmaceutical Council of Western Australia
21 Hamilton Street
SUBIACO 6008

RE:

"THE SUPPLY OF NEEDLES AND SYRINGES TO INJECTING
DRUG USERS: ATTITUDES AND PRACTICES OF PHARMACISTS
IN WESTERN AUSTRALIA"

Dear Mr Brennan,
The data gathering process in the above survey has been concluded. The sample
of 130 pharmacists selected to take part have shown overwhelming cooperation
with this project. A response rate of 89% has been achieved, an excellent return
for a survey of this kind. Such a response ensures that the findings will better
represent the views of Western Australian pharmacists.
The assistance given by your organisation in the planning of the study and
preparation of the questionnaire are very much appreciated and have aided the
smooth execution of the data gathering process.
The data analysis is currently being undertaken and the research report prepared.
This is expected to be finalised towards the end of the year when a copy of the
results will be forwarded to you.
Yours faithfully,

June New bey, Honours Student

Celia Wilkinson, Lecturer Health Studies.
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APPENDIX P
Flowchart of Pharmacists' Response

Population of WA Community Phannacists

=
Random Sample
N= 130

Total Metropolitan Returned

n =7e
" NR

=Not Received

Total Country Returned
n =42

(Pharmacist claimed to have returned the questionnaire but it was not received).
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